<SEC-DOCUMENT>0000950103-25-013806.txt : 20251029
<SEC-HEADER>0000950103-25-013806.hdr.sgml : 20251029
<ACCEPTANCE-DATETIME>20251029150053
ACCESSION NUMBER:		0000950103-25-013806
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20251029
DATE AS OF CHANGE:		20251029

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251429553

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251429554

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp236486_424b2-us2522031d.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Pricing Supplement No. 2025-USNCH29006 to Product Supplement No. EA-04-10
dated March 7, 2023,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Underlying Supplement No. 11 dated March 7, 2023, Prospectus Supplement
and Prospectus each dated March 7, 2023</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Filed Pursuant to Rule 424(b)(2)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Registration Statement Nos. 333-270327 and 333-270327-01</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Dated October 28, 2025</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Citigroup Global Markets Holdings Inc. $4,700,000 Trigger Autocallable
Contingent Yield Notes&#9;</B></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Linked to the Least Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>,
the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index Due November 1, 2028</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>All payments due on the notes are fully and unconditionally guaranteed
by Citigroup Inc.&#9;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Investment Description</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Trigger Autocallable Contingent Yield Notes (the &ldquo;<B>notes</B>&rdquo;)
are unsecured, unsubordinated debt obligations of Citigroup Global Markets Holdings Inc. (the &ldquo;<B>issuer</B>&rdquo;), guaranteed
by Citigroup Inc. (the &ldquo;<B>guarantor</B>&rdquo;), linked to the <B>least performing</B> of the Nasdaq-100 Index<SUP>&reg;</SUP>,
the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index (each, an &ldquo;<B>underlying</B>&rdquo;). The notes
will pay a contingent coupon on each quarterly coupon payment date if, <B>and only if</B>, the closing level of the least performing underlying
on the related quarterly valuation date is greater than or equal to its coupon barrier. If the closing level of the least performing underlying
on a quarterly valuation date is less than its coupon barrier, no contingent coupon will be paid on the related coupon payment date. Beginning
approximately three months after issuance, if the closing level of the least performing underlying on a quarterly valuation date is greater
than or equal to its initial underlying level, we will automatically call the notes and pay you the stated principal amount per note plus
the contingent coupon for that valuation date, and no further amounts will be owed to you. At maturity, if the notes have not previously
been automatically called, the amount you receive will depend on the final underlying level of the least performing underlying on the
final valuation date. If the final underlying level of the least performing underlying on the final valuation date is greater than or
equal to its downside threshold, you will receive the stated principal amount of your notes at maturity (plus the final contingent coupon
payment). However, if the notes have not been automatically called prior to maturity and the final underlying level of the least performing
underlying on the final valuation date is less than its downside threshold, you will receive less than the stated principal amount of
your notes at maturity, resulting in a loss that is proportionate to the decline in the closing level of the least performing underlying
from the trade date to the final valuation date, up to a 100% loss of your investment. On each valuation date, the least performing underlying
is the underlying with the lowest underlying return from the trade date to that valuation date. <B>Investing in the notes involves significant
risks. You may lose a substantial portion or all of your initial investment. The stated payout on the notes is based <U>solely</U> on
the performance of the least performing underlying. You will not benefit in any way from the performance of the better performing underlyings.
You will therefore be adversely affected if <U>any underlying</U> performs poorly, regardless of the performance of the other underlyings.
You will not receive dividends or other distributions paid on any stocks included in the underlyings or participate in any appreciation
of any underlying. The contingent repayment of the stated principal amount applies only if you hold the notes to maturity or earlier automatic
call. Any payment on the notes, including any repayment of the stated principal amount, is subject to the creditworthiness of the issuer
and the guarantor and is not, either directly or indirectly, an obligation of any third party. If the issuer and the guarantor were to
default on their payment obligations, you may not receive any amounts owed to you under the notes and you could lose your entire investment.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 96%; background-color: #788D41; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Features</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 3%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR>
    <TD ROWSPAN="6" STYLE="vertical-align: top">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 12.6pt; text-indent: -12.6pt"><FONT STYLE="font-family: Wingdings">q</FONT>&nbsp;<B>Contingent
    Coupon</B> &mdash; We will pay you a contingent coupon on each quarterly coupon payment date if, <B>and only if,</B> the closing level
    of the least performing underlying on the related valuation date is greater than or equal to its coupon barrier. Otherwise, no contingent
    coupon will be paid for that quarter.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 12.6pt; text-indent: -12.6pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 12.6pt; text-indent: -12.6pt"><FONT STYLE="font-family: Wingdings">q</FONT>&nbsp;<B>Automatic
    Call </B>&mdash; Beginning approximately three months after issuance, we will automatically call the notes and pay you the stated principal
    amount per note plus the final contingent coupon payment if the closing level of the least performing underlying on a quarterly valuation
    date is greater than or equal to its initial underlying level. If the notes are not automatically called, investors may have full downside
    market exposure to the least performing underlying at maturity.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 12.6pt; text-indent: -12.6pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 12.6pt; text-indent: -12.6pt"><FONT STYLE="font-family: Wingdings">q</FONT>&nbsp;<B>Downside
Exposure with Contingent Repayment of Principal at Maturity </B>&mdash; If the notes are not automatically called prior to maturity and
the final underlying level of the least performing underlying on the final valuation date is greater than or equal to its downside threshold,
you will receive the stated principal amount of your notes at maturity (plus the final contingent coupon payment). However, if the final
underlying level of the least performing underlying on the final valuation date is less than its downside threshold, you will receive
less than the stated principal amount of your notes at maturity, resulting in a loss that is proportionate to the decline in the closing
level of the least performing underlying from the trade date to the final valuation date, up to a 100% loss of your investment. <B>Any
payment on the notes is subject to the creditworthiness of the issuer and guarantor. If the issuer and the guarantor were to default
on their obligations, you might not receive any amounts owed to you under the notes and you could lose your entire investment.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 12.6pt; text-indent: -12.6pt"></P></TD>
    <TD ROWSPAN="6" STYLE="vertical-align: top; font-size: 12pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>

<DIV STYLE="float: right; width: 49%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Key Dates</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%; font-size: 12pt"><FONT STYLE="font-size: 10pt">Trade date</FONT></TD>
    <TD STYLE="width: 53%; padding-left: 82.55pt; font-size: 12pt; text-indent: -82.55pt"><FONT STYLE="font-size: 10pt">October 28, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Settlement date</FONT></TD>
    <TD STYLE="padding-left: 82.55pt; font-size: 12pt; text-indent: -82.55pt"><FONT STYLE="font-size: 10pt">October 31, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Valuation dates<SUP>1</SUP></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Quarterly, beginning on January 28, 2026 (See page PS-6)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Final valuation date<SUP>1</SUP></FONT></TD>
    <TD STYLE="padding-left: 13.7pt; font-size: 12pt; text-indent: -13.7pt"><FONT STYLE="font-size: 10pt">October 30, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Maturity date</FONT></TD>
    <TD STYLE="padding-left: 82.55pt; font-size: 12pt; text-indent: -82.55pt"><FONT STYLE="font-size: 10pt">November 1, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-left: 13.7pt; font-size: 12pt; text-indent: -13.7pt"><FONT STYLE="font-size: 10pt"><SUP>1&#9;</SUP>See page PS-6 for additional details. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>NOTICE TO INVESTORS: <FONT STYLE="text-transform: uppercase">The
notes are significantly riskier than conventional debt INSTRUMENTS. THE ISSUER IS NOT NECESSARILY OBLIGATED TO REPAY THE STATED PRINCIPAL
AMOUNT OF THE NOTES AT MATURITY, AND the notes CAN have downside MARKET risk SIMILAR TO the LEAST PERFORMING UNDERLYING. This MARKET risk
is in addition to the CREDIT risk INHERENT IN PURCHASING A DEBT OBLIGATION OF CITIGROUP GLOBAL MARKETS HOLDINGS INC. THAT IS GUARANTEED
BY CITIGROUP INC.&nbsp; You should not PURCHASE the notes if you do not understand or are not comfortable with the significant risks INVOLVED
in INVESTING IN the notes.</FONT></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>YOU SHOULD CAREFULLY CONSIDER THE RISKS DESCRIBED UNDER &lsquo;&lsquo;SUMMARY
RISK FACTORS&rsquo;&rsquo; BEGINNING ON PAGE PS-7 OF THIS PRICING SUPPLEMENT AND UNDER &lsquo;&lsquo;RISK FACTORS RELATING TO THE SECURITIES&rsquo;&rsquo;
BEGINNING ON PAGE EA-7 OF THE ACCOMPANYING PRODUCT SUPPLEMENT IN CONNECTION WITH YOUR PURCHASE OF THE NOTES. EVENTS RELATING TO ANY OF
THOSE RISKS, OR OTHER RISKS AND UNCERTAINTIES, COULD ADVERSELY AFFECT THE MARKET VALUE OF, AND THE RETURN ON, YOUR NOTES. YOU MAY LOSE
SOME OR ALL OF YOUR INITIAL INVESTMENT IN THE NOTES. THE NOTES WILL NOT BE LISTED ON ANY SECURITIES EXCHANGE AND MAY HAVE LIMITED OR NO
LIQUIDITY.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Notes Offering</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.4pt">We are offering Trigger Autocallable Contingent Yield Notes
Linked to the Least Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP>
Index. Any payment on the notes will be based on the performance of the least performing underlying. The notes are our unsecured, unsubordinated
debt obligations, guaranteed by Citigroup Inc., and are offered for a minimum investment of 100 notes at the issue price described below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.4pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 16%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Underlyings</B></FONT></TD>
    <TD STYLE="width: 16%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon Rate</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 15%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Initial Underlying Levels</B></FONT></TD>
    <TD STYLE="width: 23%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Coupon Barriers</B></FONT></TD>
    <TD STYLE="width: 20%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Downside Thresholds</B></FONT></TD>
    <TD STYLE="width: 10%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>CUSIP/ISIN</B></FONT></TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Nasdaq-100 Index<SUP>&reg;</SUP></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(Ticker: NDX)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD ROWSPAN="3" STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">9.70% per annum</FONT></TD>
    <TD STYLE="white-space: nowrap; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">26,012.16</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">18,208.51, which is 70% of the applicable initial underlying level</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">18,208.51, which is 70% of the applicable initial underlying level</FONT></TD>
    <TD ROWSPAN="3" STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">17333P130 / US17333P1306</FONT></TD></TR>
  <TR>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Russell 2000<SUP>&reg;</SUP> Index (Ticker: RTY)</FONT></TD>
    <TD STYLE="white-space: nowrap; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">2,506.650</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">1,754.655, which is 70% of the applicable initial underlying level</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">1,754.655, which is 70% of the applicable initial underlying level</FONT></TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">S&amp;P 500<SUP>&reg;</SUP> Index&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(Ticker: SPX)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="white-space: nowrap; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">6,890.89</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">4,823.62, which is 70% of the applicable initial underlying level</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">4,823.62, which is 70% of the applicable initial underlying level</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>See &ldquo;Additional Terms Specific to the Notes&rdquo; in this
pricing supplement. The notes will have the terms specified in the accompanying product supplement, underlying supplement, prospectus
supplement and prospectus, as supplemented by this pricing supplement. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Neither the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;)
nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing
supplement or the accompanying product supplement, underlying supplement, prospectus supplement and prospectus. Any representation to
the contrary is a criminal offense. The notes are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance
Corporation or any other governmental agency.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 25%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 28%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Issue Price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 22%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Underwriting Discount<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 25%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Proceeds<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT>to<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT>Issuer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">Per note</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$10.00</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$0.20</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$9.80</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">Total</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$4,700,000.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$94,000.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$4,606,000.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><SUP>(1)</SUP> On the date of this pricing supplement,
the estimated value of the notes is $9.826 per note, which is less than the issue price. The estimated value of the notes is based on
proprietary pricing models of Citigroup Global Markets Inc. (&ldquo;<B>CGMI</B>&rdquo;) and our internal funding rate. It is not an indication
of actual profit to CGMI or other of our affiliates, nor is it an indication of the price, if any, at which CGMI or any other person may
be willing to buy the notes from you at any time after issuance. See &ldquo;Valuation of the Notes&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><SUP>(2)</SUP> The underwriting discount is $0.20
per note. CGMI, acting as principal, has agreed to purchase from Citigroup Global Markets Holdings Inc., and Citigroup Global Markets
Holdings Inc. has agreed to sell to CGMI, the aggregate stated principal amount of the notes set forth above for $9.80 per note. UBS Financial
Services Inc. (&ldquo;<B>UBS</B>&rdquo;), acting as agent for sales of the notes, has agreed to purchase from CGMI, and CGMI has agreed
to sell to UBS, all of the notes for $9.80 per note. UBS will receive an underwriting discount of $0.20 for each note it sells in this
offering. UBS proposes to offer the notes to the public at a price of $10.00 per note. For additional information on the distribution
of the notes, see &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement. In addition to the underwriting discount,
CGMI and its affiliates may profit from hedging activity related to this offering, even if the value of the notes declines. See &ldquo;Use
of Proceeds and Hedging&rdquo; in the accompanying prospectus.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-indent: 0in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Citigroup Global Markets Inc.</B></FONT></TD>
    <TD STYLE="text-align: right; width: 50%; text-indent: 0in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>UBS Financial Services Inc.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Additional Terms Specific to the Notes</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the notes are set forth in the accompanying product supplement,
prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying product supplement, prospectus supplement
and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, certain events may occur that
could affect whether you receive a contingent coupon payment on a coupon payment date, whether the notes are automatically called prior
to maturity and whether you are repaid the stated principal amount of your notes at maturity. These events and their consequences are
described in the accompanying product supplement in the sections &ldquo;Description of the Securities&mdash;Consequences of a Market Disruption
Event; Postponement of a Valuation Date&rdquo; and &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities
Linked to an Underlying Index&mdash;Discontinuance or Material Modification of an Underlying Index,&rdquo; and not in this pricing supplement.
The accompanying underlying supplement contains important disclosures regarding the underlyings that are not repeated in this pricing
supplement. It is important that you read the accompanying product supplement, underlying supplement, prospectus supplement and prospectus
together with this pricing supplement in connection with your investment in the notes. Certain terms used but not defined in this pricing
supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You may access the accompanying product supplement, underlying supplement,
prospectus supplement and prospectus on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings
for the relevant dates on the SEC website):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 14.45pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><FONT STYLE="background-color: white">Product Supplement No. EA-04-10 dated March 7, 2023:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 14.45pt"><FONT STYLE="background-color: white"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003814/dp190219_424b2-coba0410.htm">https://www.sec.gov/Archives/edgar/data/200245/000095010323003814/dp190219_424b2-coba0410.htm</A></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 14.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 14.45pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><FONT STYLE="background-color: white">Underlying Supplement No. 11 dated March 7, 2023:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 14.45pt"><FONT STYLE="background-color: white"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm">https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm</A></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 14.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 14.45pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><FONT STYLE="background-color: white">Prospectus Supplement and Prospectus each dated March 7, 2023:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 14.45pt"><FONT STYLE="background-color: white"><A HREF="https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm">https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm</A></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 14.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">References to &ldquo;Citigroup Global Markets Holdings Inc.,&rdquo;
&ldquo;Citigroup,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; and &ldquo;us&rdquo; refer to Citigroup Global Markets Holdings Inc. and
not to any of its subsidiaries. References to &ldquo;Citigroup Inc.&rdquo; refer to Citigroup Inc. and not to any of its subsidiaries.
In this pricing supplement, &ldquo;notes&rdquo; refers to the Trigger Autocallable Contingent Yield Notes Linked to the Least Performing
of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index that are offered
hereby, unless the context otherwise requires.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>This pricing supplement, together with the documents listed above,
contains the terms of the notes and supersedes all other prior or contemporaneous oral statements as well as any other written materials
including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures
or other educational materials of ours. The description in this pricing supplement of the particular terms of the notes supplements, and,
to the extent inconsistent with, replaces, the descriptions of the general terms and provisions of the debt securities set forth in the
accompanying product supplement, prospectus supplement and prospectus. You should carefully consider, among other things, the matters
set forth in &ldquo;Summary Risk Factors&rdquo; in this pricing supplement and &ldquo;Risk Factors Relating to the Securities&rdquo; in
the accompanying product supplement, as the notes involve risks not associated with conventional debt securities. We urge you to consult
your investment, legal, tax, accounting and other advisers in connection with your decision to invest in the notes.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Investor Suitability</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The suitability considerations identified below are not exhaustive.
Whether or not the notes are a suitable investment for you will depend on your individual circumstances, and you should reach an investment
decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered the suitability of an
investment in the notes in light of your particular circumstances. You should also review &ldquo;Summary Risk Factors&rdquo; beginning
on page PS-7 of this pricing supplement, <FONT STYLE="background-color: white">&ldquo;The Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; beginning
on page PS-14 of this pricing supplement, &ldquo;The Russell 2000<SUP>&reg;</SUP> Index&ldquo; beginning on page PS-15 of this pricing
supplement, &ldquo;The S&amp;P 500<SUP>&reg;</SUP> Index&ldquo; beginning on page PS-16 of this pricing supplement, &ldquo;Risk Factors
Relating to the Securities&rdquo; beginning on page EA-7 of the accompanying product supplement, </FONT>&ldquo;Equity Index Descriptions&mdash;
The Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; beginning on page US-26 <FONT STYLE="background-color: white">of the accompanying underlying
supplement, </FONT>&ldquo;Equity Index Descriptions&mdash;The Russell Indices&rdquo; beginning on page US-37 <FONT STYLE="background-color: white">of
the accompanying underlying supplement and &ldquo;</FONT>Equity Index Descriptions&mdash;The S&amp;P U.S. Indices&rdquo; beginning on
page US-58 of the accompanying underlying supplement<FONT STYLE="background-color: white">.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>The notes may be suitable for you if, among other considerations:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You fully understand the risks inherent in an investment in the notes, including the risk of loss of your entire initial investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You can tolerate a loss of all or a substantial portion of your initial investment and are willing to make an investment that may
have the full downside market risk of an investment in the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You understand and accept the risks associated with each of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the closing level of each underlying is likely to be greater than or equal to its respective coupon barrier on the valuation
dates, and, if the closing level of any underlying is not, you can tolerate receiving few or no contingent coupon payments over the term
of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the closing level of each underlying will be greater than or equal to its downside threshold on the final valuation date,
and, if the closing level of any underlying is below its downside threshold on the final valuation date, you can tolerate a loss of all
or a substantial portion of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You can tolerate fluctuations in the value of the notes prior to maturity that may be similar to or exceed the downside fluctuations
in the level of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You understand that your return will be based on the performance of the least performing underlying and you will not benefit from
the performance of the other underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to hold notes that will be called on the earliest valuation date (beginning three months after issuance) on which
the closing level of the least performing underlying is greater than or equal to its respective initial underlying level, and you are
otherwise willing to hold such notes to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to make an investment whose positive return is limited to the contingent coupon payments, regardless of the potential
appreciation of the underlyings, which could be significant.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><FONT STYLE="background-color: white">You are willing to invest in the notes based on the contingent coupon rate indicated on the
cover page of this pricing supplement</FONT>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to invest in the notes based on the coupon barriers and downside thresholds indicated on the cover page of this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing and able to hold the notes to maturity, and accept that there may be little or no secondary market for the notes and
that any secondary market will depend in large part on the price, if any, at which CGMI is willing to purchase the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not seek guaranteed current income from your investment and are willing to forgo dividends or any other distributions paid
on the stocks included in the underlyings for the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to assume the credit risk of Citigroup Global
Markets Holdings Inc. and Citigroup Inc. for all payments under the notes, and understand that if Citigroup Global Markets Holdings Inc.
and Citigroup Inc. default on their obligations, you might not receive any amounts due to you, including any repayment of the stated
principal amount.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt"></P>

</DIV>

<DIV STYLE="float: right; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt"><B>The notes may <I>not</I> be suitable for you if, among
other considerations:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not fully understand the risks inherent in an investment in the notes, including the risk of loss of your entire initial investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You cannot tolerate the loss of all or a substantial portion of your initial investment, or you are not willing to make an investment
that may have the full downside market risk of an investment in the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not understand or are not willing to accept the risks associated with each of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not believe the closing level of each underlying is likely to be greater than or equal to its respective coupon barrier on
the valuation dates, or you cannot tolerate receiving few or no contingent coupon payments over the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the closing level of any underlying will be less than its respective downside threshold on the final valuation date, exposing
you to the full downside performance of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You require an investment designed to guarantee a full return of the stated principal amount at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You cannot tolerate fluctuations in the value of the notes prior to maturity that may be similar to or exceed the downside fluctuations
in the level of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to accept that your return will be based on the performance of the least performing underlying, or you seek an investment
based on the performance of a basket composed of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to hold notes that will be called on the earliest valuation date (beginning three months after issuance) on which
the closing level of the least performing underlying is greater than or equal to its respective initial underlying level, or you are otherwise
unable or unwilling to hold such notes to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek an investment that participates in the full appreciation of the underlyings and whose positive return is not limited to the
contingent coupon payments.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><FONT STYLE="background-color: white">You are unwilling to invest in the notes based on the contingent coupon rate indicated on the
cover page of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to invest in the notes based on the coupon barriers and downside thresholds indicated on the cover page of this
pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek an investment for which there will be an active secondary market.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek guaranteed current income from this investment or prefer to receive the dividends and any other distributions paid on the
stocks included in the underlyings for the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You prefer the lower risk of conventional fixed income investments with comparable maturities and credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are not willing to assume the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. for all payments under
the notes, including any repayment of the stated principal amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; color: white"><B>Final Terms</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%"><FONT STYLE="font-size: 10pt">Issuer</FONT></TD>
    <TD STYLE="width: 66%"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Guarantee</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">All payments due on the notes are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Issue price</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">100% of the stated principal amount per note</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Stated principal amount per note</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$10.00 per note</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Term</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Approximately three years, unless earlier automatically called</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Trade date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">October 28, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Settlement date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">October 31, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Final valuation date<SUP>1</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">October 30, 2028</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Maturity date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">November 1, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Underlyings</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"><FONT STYLE="background-color: white">Nasdaq-100 Index<SUP>&reg;</SUP>
    (Ticker: NDX)</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"><FONT STYLE="background-color: white">Russell 2000<SUP>&reg;</SUP>
    Index (Ticker: RTY)</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">S&amp;P 500<SUP>&reg;</SUP> Index (Ticker: SPX)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Automatic call feature</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">The notes will be automatically called if the closing level
    of the least performing underlying on any valuation date occurring on or after January 28, 2026 is greater than or equal to its initial
    underlying level.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">If the notes are automatically called, we will pay you on
    the applicable coupon payment date a cash payment per $10.00 stated principal amount of each note equal to the stated principal amount
    per note plus the contingent coupon for the applicable valuation date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">After the notes are automatically called, no further payments
    will be made on the notes.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Valuation dates<SUP>1</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">See &ldquo;Valuation Dates/Coupon Payment Dates for the Offering of the Notes&rdquo; on page PS-6.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Coupon payment dates</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Two (2) business days following the applicable valuation date, except that the coupon payment date for the final valuation date is the maturity date. See &ldquo;Valuation Dates/Coupon Payment Dates for the Offering of the Notes&rdquo; on page PS-6.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Contingent coupon/contingent coupon rate</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">If the closing level of the least performing underlying on
    a quarterly valuation date is greater than or equal to its coupon barrier, we will make a contingent coupon payment with respect to that
    valuation date on the related coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">However, if the closing level of the least performing underlying
    on a quarterly valuation date is below its coupon barrier, no contingent coupon will be payable on the related coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">Each contingent coupon payment will be in the amount of $0.2425
    for each $10.00 stated principal amount note (based on the per annum contingent coupon rate of 9.70%) and will be payable with respect
    to each valuation date on which the closing level of the least performing underlying on that valuation date is greater than or equal to
    its coupon barrier.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0"><B>Contingent coupon payments on the notes are not guaranteed.
    We will not pay you the contingent coupon for any valuation date on which the closing level of least performing </B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">____________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><SUP>1</SUP> Subject to postponement as described under &ldquo;Description of the Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Valuation Date&rdquo; in the accompanying product supplement.</TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: right; width: 49%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 66%"><FONT STYLE="font-size: 10pt"><B>underlying on that valuation date is less than its coupon barrier.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Payment at maturity (per $10.00 stated principal amount of notes)</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the notes are not automatically called prior to maturity and the
    final underlying level of the least performing underlying on the final valuation date is greater than or equal to its downside threshold</B>,
    we will pay you the $10.00 stated principal amount plus the contingent coupon with respect to the final valuation date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the notes are not automatically called prior to maturity and the
    final underlying level of the least performing underlying on the final valuation date is less than its downside threshold, </B>we will
    pay you a cash payment on the maturity date that is less than your stated principal amount and may be zero, resulting in a loss that is
    proportionate to the negative underlying return of the least performing underlying on the final valuation date, equal to:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-decoration: none double">$10.00</FONT>
    &times; (1 + underlying return of the least performing underlying on the final valuation date)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Accordingly, you may lose all or a substantial portion of your
    stated principal amount at maturity, depending on how significantly the least performing underlying declines.</I></B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Least performing underlying</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">On each valuation date, including the final valuation date, the underlying with the lowest underlying return as of that valuation date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Underlying return</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For any underlying on any valuation date, calculated as follows:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><U>current underlying level &ndash; initial underlying
    level<BR>
    </U>initial underlying level</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Downside threshold</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any underlying, 70% of the applicable initial underlying level, as specified on the cover page of this pricing supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Coupon barrier</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any underlying, 70% of the applicable initial underlying level, as specified on the cover page of this pricing supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Initial underlying level</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any underlying, its closing level on the trade date, as specified on the cover page of this pricing supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Current underlying level</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any underlying and any valuation date, the closing level of that underlying on that valuation date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Final underlying level</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any underlying, its closing level on the final valuation date.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>INVESTING IN THE NOTES INVOLVES SIGNIFICANT RISKS. YOU MAY LOSE&nbsp;A SUBSTANTIAL PORTION OR ALL OF YOUR INITIAL INVESTMENT.&nbsp;THE CONTINGENT REPAYMENT OF THE STATED PRINCIPAL AMOUNT APPLIES ONLY IF YOU HOLD THE NOTES TO MATURITY. ANY PAYMENT ON THE NOTES IS SUBJECT TO THE CREDITWORTHINESS OF THE ISSUER AND THE GUARANTOR. IF CITIGROUP GLOBAL MARKETS HOLDINGS INC. AND CITIGROUP INC. WERE TO DEFAULT ON THEIR OBLIGATIONS, YOU MIGHT NOT RECEIVE ANY AMOUNTS OWED TO YOU UNDER THE NOTES AND YOU COULD LOSE YOUR ENTIRE INVESTMENT.</B> &nbsp;</P>



<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD COLSPAN="4"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Investment Timeline</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; background-color: white; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; background-color: #DEDFB3; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Trade date</B></FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The closing level of each underlying (its respective initial underlying level) is observed, the contingent coupon rate is set and the coupon barrier and downside threshold for each underlying are determined. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 16px; width: 20px"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; background-color: #DEDFB3">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Quarterly</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>(autocallable after three months) </B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">If the closing level of the least performing underlying on any
    quarterly valuation date is greater than or equal to its coupon barrier, we will pay you a contingent coupon on the related coupon payment
    date. However, if the closing level of the least performing underlying on any quarterly valuation date is below its coupon barrier, no
    coupon will be payable on the related coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">The notes will be automatically called if the closing level
    of the least performing underlying on any valuation date (beginning three months after issuance) is greater than or equal to its initial
    underlying level.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">If the notes are automatically called on any valuation date,
    we will pay the stated principal amount plus the applicable contingent coupon on the related coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">After the notes are automatically called, no further payments
    will be made on the notes.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 16px; width: 20px"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; background-color: #DEDFB3; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Maturity date (if not previously automatically called)</B></FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">If the notes are not automatically called prior to maturity,
    the final underlying level of each underlying is observed on the final valuation date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0"><B>If the final underlying level of the least performing underlying
    on the final valuation date is greater than or equal to its downside threshold, </B>we will pay you the $10.00 stated principal amount
    plus the contingent coupon with respect to the final valuation date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0"><B>If the final underlying level of the least performing underlying
    on the final valuation date is less than its downside threshold</B>, we will pay you a cash payment on the maturity date that is less
    than your stated principal amount and may be zero, resulting in a loss that is proportionate to the negative underlying return of the
    least performing underlying on the final valuation date, equal to:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0; text-align: center">$10.00 &times; (1 + underlying return
of the least performing underlying on the final valuation date)&nbsp;</P></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; border-top: #788D41 3pt solid; border-bottom: #788D41 3pt solid">Valuation
Dates/Coupon Payment Dates for the Offering of the Notes</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: black"><B>Valuation Dates<SUP>1</SUP></B></FONT></TD>
    <TD STYLE="width: 52%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: black"><B>Coupon Payment Dates<SUP>2</SUP></B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 28, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 30, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 28, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 30, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 28, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 30, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 28, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 30, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 28, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">February 1, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 28, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 30, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 28, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 30, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 28, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">November 1, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 28, 2028</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">February 1, 2028</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 28, 2028</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">May 2, 2028</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 28, 2028</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">August 1, 2028</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 30, 2028</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">November 1, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>1</SUP> Subject to postponement as described under &ldquo;Description
of the Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Valuation Date&rdquo; in the accompanying product
supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>2</SUP> If any valuation date (other than the final valuation date)
is postponed, the related coupon payment date will be the second business day after such valuation date as postponed.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Summary Risk Factors</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the notes is significantly riskier than an investment
in conventional debt securities. The notes are subject to all of the risks associated with an investment in our conventional debt securities
(guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the notes, and are
also subject to risks associated with each underlying. Accordingly, the notes are suitable only for investors who are capable of understanding
the complexities and risks of the notes. You should consult your own financial, tax and legal advisers as to the risks of an investment
in the notes and the suitability of the notes in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the notes. You should read this summary together with the more detailed description of risks relating to an investment in the notes
contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product supplement.
You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated by
reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent Quarterly
Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You may lose some or all of your investment </B>&mdash; The notes differ from ordinary debt securities in that we will not necessarily
repay the full stated principal amount of your notes at maturity. If the notes are not automatically called on any of the valuation dates
(beginning three months after issuance) and the final underlying level of the least performing underlying on the final valuation date
is less than its downside threshold, you will lose 1% of the stated principal amount of the notes for every 1% by which the final underlying
level of the least performing underlying is less than its initial underlying level. There is no minimum payment at maturity on the notes,
and you may lose up to all of your investment in the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You will not receive any contingent coupon payment for any quarter in which the closing level of the least performing underlying
on the related valuation date is less than its coupon barrier</B> &mdash; A contingent coupon payment will be made on a coupon payment
date if and only if the closing level of the least performing underlying on the related valuation date is greater than or equal to its
coupon barrier. If the closing level of the least performing underlying on any valuation date is less than its coupon barrier, you will
not receive any contingent coupon payment on the related coupon payment date. If the closing level of the least performing underlying
is below its coupon barrier on each valuation date, you will not receive any contingent coupon payments over the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes are subject to the risks of each of the underlyings and will be negatively affected if any underlying performs poorly,
even if the other underlyings perform well </B>&mdash; You are subject to risks associated with any of the underlyings. If any underlying
performs poorly, you will be negatively affected, even if the other underlyings perform well. The notes are not linked to a basket composed
of the underlyings, where the better performance of one could ameliorate the poor performance of the others. Instead, you are subject
to the full risks of whichever of the underlyings is the least performing underlying on each valuation date. Furthermore, the risk that
you will not receive the contingent coupon and that you will lose some or all of your initial investment in the notes is greater if you
invest in the notes as opposed to notes that are linked to the performance of a single underlying if their terms are otherwise substantially
similar. With a greater total number of underlyings, it is more likely that an underlying will be below its coupon barrier or downside
threshold on a valuation date or the final valuation date, as applicable, and therefore it is more likely that you will not receive any
contingent coupon and that at maturity, you will receive an amount in cash which is worth less than your principal amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You will not benefit in any way from the performance of the better performing underlyings </B>&mdash; The return on the notes depends
solely on the performance of the least performing underlying, and you will not benefit in any way from the performance of the better performing
underlyings. The notes may underperform a similar investment in all of the underlyings or a similar alternative investment linked to a
basket composed of the underlyings, since in either such case the performance of the better performing underlyings would be blended with
the performance of the least performing underlying, resulting in a better return than the return of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You will be subject to risks relating to the relationship between the underlyings</B> &mdash; It is preferable from your perspective
for the underlyings to be correlated with each other, in the sense that they tend to increase or decrease at similar times and by similar
magnitudes. By investing in the notes, you assume the risk that the underlyings will not exhibit this relationship. The less correlated
the underlyings, the more likely it is that any of the underlyings will perform poorly over the term of the notes. All that is necessary
for the notes to perform poorly is for one of the underlyings to perform poorly; the performance of the underlying that is not the least
performing underlying is not relevant to your return on the notes. It is impossible to predict what the relationship between the underlyings
will be over the term of the notes. <FONT STYLE="background-color: white"><B>The Nasdaq-100 Index<SUP>&reg;</SUP> represents 100 of the
largest non-financial companies listed on the Nasdaq Stock Market, </B></FONT><B>the Russell 2000<SUP>&reg; </SUP>Index represents small
capitalization stocks in the United States and the S&amp;P 500<SUP>&reg; </SUP>Index represents large capitalization stocks in the United
States<FONT STYLE="background-color: white">. Accordingly, the underlyings represent markets that differ in significant ways and, therefore,
may not be correlated with each other.</FONT></B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Higher contingent coupon rates are associated with greater risk</B> &mdash; The notes offer contingent coupon payments at an annualized
rate that, if all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same
maturity. This higher potential yield is associated with greater levels of expected risk as of the trade date for the notes, including
the risks that you may not receive a contingent coupon payment on one or more, or any, coupon payment dates, the notes will not be automatically
called and the amount you receive at maturity may be significantly less than the stated principal amount of your notes and may be zero.
The volatility of and the correlation between the underlyings are important factors affecting these risks. Greater expected volatility
of, and lower expected correlation between, the underlyings as of the trade date may result in a higher contingent coupon rate, but would
also represent a greater expected likelihood as of the trade date that (i) the closing level of the least performing underlying will</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt">be less than the applicable coupon
barrier on one or more valuation dates, such that you will not receive one or more, or any, contingent coupon payments during the term
of the notes, (ii) the closing level of the least performing underlying will be less than the applicable initial underlying level on each
valuation date (beginning three months after issuance), such that the notes are not automatically called and (iii) the closing level of
the least performing underlying will be less than the applicable downside threshold on the final valuation date, such that you will not
be repaid the stated principal amount of your notes at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You may not be adequately compensated for assuming the downside risk of the least performing underlying</B> &mdash; The potential
contingent coupon payments on the notes are the compensation you receive for assuming the downside risk of the least performing underlying,
as well as all the other risks of the notes. That compensation is effectively &ldquo;at risk&rdquo; and may, therefore, be less than you
currently anticipate. First, the actual yield you realize on the notes could be lower than you anticipate because the coupon is &ldquo;contingent&rdquo;
and you may not receive a contingent coupon payment on one or more, or any, of the coupon payment dates. Second, the contingent coupon
payments are the compensation you receive not only for the downside risk of the least performing underlying, but also for all of the other
risks of the notes, including the risk that the notes may be called prior to maturity, interest rate risk and our and Citigroup Inc.&rsquo;s
credit risk. If those other risks increase or are otherwise greater than you currently anticipate, the contingent coupon payments may
turn out to be inadequate to compensate you for all the risks of the notes, including the downside risk of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes offer downside exposure to the least performing underlying, but no upside exposure to any underlying</B> &mdash; You
will not participate in any appreciation in the level of the underlyings over the term of the notes. Consequently, your return on the
notes will be limited to the contingent coupon payments you receive, if any, and may be significantly less than the return on the underlyings
over the term of the notes. In addition, you will not receive any dividends or other distributions or have any other rights with respect
to the underlyings or the stocks included in the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The performance of the notes will depend on the closing levels of the underlyings solely on the relevant valuation dates, which
makes the notes particularly sensitive to the volatility of the underlyings</B> &mdash; Whether the contingent coupon will be paid for
any given quarter will depend on the closing levels of the underlyings solely on the applicable quarterly valuation dates, regardless
of the closing levels of the underlyings on other days during the term of the notes. If the notes are not automatically called, what you
receive at maturity will depend solely on the closing level of the least performing underlying on the final valuation date, and not on
any other day during the term of the notes. Because the performance of the notes depends on the closing levels of the underlyings on a
limited number of dates, the notes will be particularly sensitive to volatility in the closing levels of the underlyings. You should understand
that the underlyings have historically been highly volatile.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><FONT STYLE="background-color: white"><B>Investing in the notes is not equivalent to investing in any underlying or the stocks that
constitute any underlying</B> &mdash; </FONT>You will not have voting rights, rights to receive any dividends or other distributions or
any other rights with respect to any of the stocks that constitute the underlyings. It is important to understand that, for purposes of
measuring the performance of the underlyings, the levels used will not reflect the receipt or reinvestment of dividends or distributions
on the stocks that constitute any underlying. Dividend or distribution yield on the stocks that constitute the underlyings would be expected
to represent a significant portion of the overall return on a direct investment in the stocks that constitute the underlyings, but will
not be reflected in the performance of any underlying as measured for purposes of the notes (except to the extent that dividends and distributions
reduce the levels of the underlyings).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. </B>&mdash; Any payment on
the notes will be made by Citigroup Global Markets Holdings Inc. and is guaranteed by Citigroup Inc., and therefore is subject to the
credit risk of both Citigroup Global Markets Holdings Inc. and Citigroup Inc. If we default on our obligations under the notes and Citigroup
Inc. defaults on its guarantee obligations, you may not receive any payments that become due under the notes. As a result, the value of
the notes prior to maturity will be affected by changes in the market&rsquo;s view of our and Citigroup Inc.&rsquo;s creditworthiness.
Any decline, or anticipated decline, in either of our or Citigroup Inc.&rsquo;s credit ratings or increase, or anticipated increase, in
the credit spreads charged by the market for taking either of our or Citigroup Inc.&rsquo;s credit risk is likely to adversely affect
the value of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes may be automatically called prior to maturity</B> &mdash; Beginning three months after issuance, on any valuation date
occurring quarterly during the term of the notes, the notes will be automatically called if the closing level of the least performing
underlying on that valuation date is greater than or equal to its respective initial underlying level. Thus, the term of the notes may
be limited to as short as three months. If the notes are automatically called prior to maturity, you may not be able to reinvest your
funds in another investment that provides a similar yield with a similar level of risk. Generally, the longer the notes are outstanding,
the less likely it is that they will be automatically called due to the decline in the levels of the underlyings and the shorter time
remaining for the levels of underlyings to recover.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes will not be listed on any securities exchange and you may not be able to sell them prior to maturity</B> &mdash; The
notes will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the notes. CGMI currently
intends to make a secondary market in relation to the notes and to provide an indicative bid price for the notes on a daily basis. Any
indicative bid price for the notes provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account prevailing
market conditions and other relevant factors, and will not be a representation by CGMI that the notes can be sold at that price, or at
all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for any reason.
If CGMI suspends or terminates making a market, there may be no secondary market at all for the notes because it is likely that CGMI will
be the only broker-dealer that is willing to buy your notes prior to maturity. Accordingly, an investor must be prepared to hold the notes
until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The probability that the least performing underlying will fall below the coupon barrier on any valuation date or the downside threshold
on the final valuation date will depend in part on the volatility of, and correlation between, the underlyings </B>&mdash; &ldquo;Volatility&rdquo;
refers to the frequency and magnitude of changes in the level of the underlyings. &ldquo;Correlation&rdquo; refers to the extent to which
the underlyings tend to increase or decrease at similar times and by similar magnitudes. In general, the greater the volatility of the
underlyings, and the lower the correlation between the underlyings, the greater the probability that at least one of the underlyings will
experience a large decline over the term of the notes and fall below its respective coupon barrier on one, or more, quarterly valuation
dates and/or below its respective downside threshold on the final valuation date. The underlyings have historically experienced significant
volatility, and as discussed above, the underlyings represent markets that differ in significant ways and therefore may not be correlated.
As a result, there is a significant risk that at least one of the underlyings will fall below its respective coupon barrier on one or
more valuation dates, such that you will not receive one or more contingent coupon payments, and that at least one of the underlyings
will fall below its respective downside threshold on the final valuation date, such that you will incur a significant loss on your investment
in the notes. The terms of the notes are set, in part, based on expectations about the volatility of, and correlation between, the underlyings
as of the trade date. If expectations about the volatility of, and correlation between, the underlyings change over the term of the notes,
the value of the notes may be adversely affected, and if the actual volatility of the underlyings prove to be greater than initially expected,
or if the actual correlation between the underlyings proves to be lower than initially expected, the notes may prove to be riskier than
expected on the trade date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes on the trade date, based on CGMI&rsquo;s proprietary pricing models and our internal funding rate,
is less than the issue price</B> &mdash; The difference is attributable to certain costs associated with selling, structuring and hedging
the notes that are included in the issue price. These costs include (i) the underwriting discount paid in connection with the offering
of the notes, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of the notes and (iii) the
expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection with hedging our obligations
under the notes. These costs adversely affect the economic terms of the notes because, if they were lower, the economic terms of the notes
would be more favorable to you. The economic terms of the notes are also likely to be adversely affected by the use of our internal funding
rate, rather than our secondary market rate, to price the notes. See &ldquo;The estimated value of the notes would be lower if it were
calculated based on our secondary market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes was determined for us by our affiliate using proprietary pricing models </B>&mdash; CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of and correlation between the underlyings, dividend
yields on the stocks that constitute the underlyings and interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo;
views, and as an underwriter in this offering, CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models
may prove to be wrong and therefore not an accurate reflection of the value of the notes. Moreover, the estimated value of the notes set
forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine for the notes for
other purposes, including for accounting purposes. You should not invest in the notes because of the estimated value of the notes. Instead,
you should be willing to hold the notes to maturity irrespective of the initial estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes would be lower if it were calculated based on our secondary market rate </B>&mdash; The estimated
value of the notes included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which we
are willing to borrow funds through the issuance of the notes. Our internal funding rate is generally lower than our secondary market
rate, which is the rate that CGMI will use in determining the value of the notes for purposes of any purchases of the notes from you in
the secondary market. If the estimated value included in this pricing supplement were based on our secondary market rate, rather than
our internal funding rate, it would likely be lower. We determine our internal funding rate based on factors such as the costs associated
with the notes, which are generally higher than the costs associated with conventional debt securities, and our liquidity needs and preferences.
Our internal funding rate is not the same as the contingent coupon rate that is payable on the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Because there is not an active market for
traded instruments referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of
traded instruments referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the
notes, but subject to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined
measure of our creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted
for discretionary factors such as CGMI&rsquo;s preferences with respect to purchasing the notes prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes is not an indication of the price, if any, at which CGMI or any other person may be willing to
buy the notes from you in the secondary market</B> &mdash; Any such secondary market price will fluctuate over the term of the notes based
on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included in this pricing supplement,
any value of the notes determined for purposes of a secondary market transaction will be based on our secondary market rate, which will
likely result in a lower value for the notes than if our internal funding rate were used. In addition, any secondary market price for
the notes will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount of the notes to be purchased
in the secondary market transaction, and the expected cost of unwinding related hedging transactions. As a result, it is likely that any
secondary market price for the notes will be less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The value of the notes prior to maturity will fluctuate based on many unpredictable factors </B>&mdash; As described under &ldquo;Valuation
of the Notes&rdquo; below, the payout on the notes could be replicated by a hypothetical package of financial instruments consisting of
a fixed-income bond and one or more derivative instruments. As a result, the factors that influence the values of fixed-income bonds and
derivative instruments will also influence the terms of the notes at issuance and the value of the notes prior to maturity. Accordingly,
the value of your notes prior to maturity will fluctuate based on the level and volatility of the underlyings and a number of other factors,</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt">including the price and volatility
of the stocks that constitute the underlyings, the correlation between the underlyings, dividend yields on the stocks that constitute
the underlyings, interest rates generally, the time remaining to maturity and our and Citigroup Inc.&rsquo;s creditworthiness, as reflected
in our secondary market rate. Changes in the levels of the underlyings may not result in a comparable change in the value of your notes.
You should understand that the value of your notes at any time prior to maturity may be significantly less than the issue price. The stated
payout from the issuer only applies if you hold the notes to maturity or earlier automatic call, as applicable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment</B> &mdash; The amount of this temporary
upward adjustment will decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Notes&rdquo; in this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The Nasdaq-100 Index<SUP>&reg;</SUP> is subject to risks associated with the stocks of foreign companies</B> &mdash; Some of the
stocks that constitute the Nasdaq-100 Index<SUP>&reg;</SUP> are issued by foreign companies. Investments in securities of foreign companies
involve risks associated with those countries, including risks of governmental intervention and cross-shareholdings in companies in certain
countries. The prices of securities issued by foreign companies may be affected by political, economic, financial and social factors in
those countries, or global regions, including changes in government, economic and fiscal policies and currency exchange laws.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The Russell 2000<SUP>&reg; </SUP>Index is subject to risks associated with small capitalization stocks </B>&mdash; <FONT STYLE="background-color: white">The
stocks that constitute the Russell 2000<SUP>&reg;</SUP> Index are issued by companies with relatively small market capitalization.&nbsp;
The stock prices of smaller companies may be more volatile than the stock prices of large capitalization companies.&nbsp; These companies
tend to be less well-established than large market capitalization companies.&nbsp; Small capitalization companies may be less able to
withstand adverse economic, market, trade and competitive conditions relative to larger companies.&nbsp; Small capitalization companies
are less likely to pay dividends on their stocks, and the presence of a dividend payment could be a factor that limits downward stock
price pressure under adverse market conditions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Our offering of the notes is not a recommendation of any underlying </B>&mdash; The fact that we are offering the notes does not
mean that we believe that investing in an instrument linked to the least performing underlying is likely to achieve favorable returns.
In fact, as we are part of a global financial institution, our affiliates may have positions (including short positions) in the stocks
that constitute the underlyings or in instruments related to the underlyings or the stocks that constitute the underlyings, and may publish
research or express opinions, that in each case are inconsistent with an investment linked to the underlyings. These and other activities
of our affiliates may affect the levels of the underlyings in a way that has a negative impact on your interests as a holder of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Our affiliates, or UBS or its affiliates, may publish research, express opinions or provide recommendations that are inconsistent
with investing in or holding the notes</B> &mdash; Any such research, opinions or recommendations could affect the closing levels of the
underlyings and the value of the notes. Our affiliates, and UBS and its affiliates, publish research from time to time on financial markets
and other matters that may influence the value of the notes, or express opinions or provide recommendations that may be inconsistent with
purchasing or holding the notes. Any research, opinions or recommendations expressed by our affiliates or by UBS or its affiliates may
not be consistent with each other and may be modified from time to time without notice. These and other activities of our affiliates or
UBS or its affiliates may adversely affect the levels of the underlyings and may have a negative impact on your interests as a holder
of the notes. Investors should make their own independent investigation of the merits of investing in the notes and the underlyings to
which the notes are linked.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Trading and other transactions by our affiliates, or by UBS or its affiliates, in the equity and equity derivative markets may
impair the value of the notes </B>&mdash; We have hedged our exposure under the notes through CGMI or other of our affiliates, who have
entered into equity and/or equity derivative transactions, such as over-the-counter options or exchange-traded instruments, relating to
the underlyings or the stocks included in the underlyings and may adjust such positions during the term of the notes. It is possible that
our affiliates could receive substantial returns from these hedging activities while the value of the notes declines. Our affiliates and
UBS and its affiliates may also engage in trading in instruments linked to the underlyings on a regular basis as part of their respective
general broker-dealer and other businesses, for proprietary accounts, for other accounts under management or to facilitate transactions
for customers, including block transactions. Such trading and hedging activities may affect the levels of the underlyings and reduce the
return on your investment in the notes. Our affiliates or UBS or its affiliates may also issue or underwrite other securities or financial
or derivative instruments with returns linked or related to the underlyings. By introducing competing products into the marketplace in
this manner, our affiliates or UBS or its affiliates could adversely affect the value of the notes. Any of the foregoing activities described
in this paragraph may reflect trading strategies that differ from, or are in direct opposition to, investors&rsquo; trading and investment
strategies relating to the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Our affiliates, or UBS or its affiliates, may have economic interests that are adverse to yours as a result of their respective
business activities </B>&mdash; Our affiliates or UBS or its affiliates may currently or from time to time engage in business with the
issuers of the stocks that constitute the underlyings, including extending loans to, making equity investments in or providing advisory
services to such issuers. In the course of this business, our affiliates or UBS or its affiliates may acquire non-public information about
those issuers, which they will not disclose to you. Moreover, if any of our affiliates or UBS or any of its affiliates is or becomes a
creditor of any such issuer, they may exercise any remedies against that issuer that are available to them without regard to your interests.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the notes </B>&mdash;
If certain events occur, such as market disruption events or the discontinuance of an underlying, CGMI, as calculation agent, will be
required to make discretionary judgments that could significantly affect the payments on the notes. Such judgments could include, among
other things:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>determining whether a market disruption event has occurred with respect to an underlying;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>if a market disruption event occurs on any valuation date with respect to an underlying, determining whether to postpone the valuation
date;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>determining the levels of the underlyings if the levels of the underlyings are not otherwise available or a market disruption event
has occurred; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>selecting a successor underlying or performing an alternative calculation of the level of an underlying if an underlying is discontinued
or materially modified (see &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying
Index&mdash;Discontinuance or Material Modification of an Underlying Index&rdquo; in the accompanying product supplement).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">In making these judgments, the calculation agent&rsquo;s
interests as an affiliate of ours could be adverse to your interests as a holder of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Adjustments to any underlying may affect the value of your notes</B> &mdash; <FONT STYLE="background-color: white">Nasdaq, Inc.,
as publisher of the Nasdaq-100 Index<SUP>&reg;</SUP>, </FONT>FTSE Russell, as publisher of the Russell 2000<SUP>&reg;</SUP> Index and
S&amp;P Dow Jones Indices LLC, as publisher of the S&amp;P 500<SUP>&reg;</SUP> Index<FONT STYLE="background-color: white">, may add, delete
or substitute the stocks that constitute any underlying or make other methodological changes that could affect the level of any underlying.
Nasdaq, Inc., </FONT>FTSE Russell <FONT STYLE="background-color: white">or </FONT>S&amp;P Dow Jones Indices LLC <FONT STYLE="background-color: white">may
discontinue or suspend calculation or publication of any underlying at any time without regard to your interests as holders of the notes.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in the notes are unclear </B>&mdash; There is no direct legal authority regarding
the proper U.S. federal tax treatment of the notes, and we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;).
Consequently, significant aspects of the tax treatment of the notes are uncertain, and the IRS or a court might not agree with the treatment
of the notes as described in &ldquo;United States Federal Tax Considerations&rdquo; below. If the IRS were successful in asserting an
alternative treatment of the notes, the tax consequences of the ownership and disposition of the notes might be materially and adversely
affected. Moreover, future legislation, Treasury regulations or IRS guidance could adversely affect the U.S. federal tax treatment of
the notes, possibly retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Non-U.S. investors should note that persons
having withholding responsibility in respect of the notes may withhold on any coupon payment paid to a non-U.S. investor, generally at
a rate of 30%. To the extent that we have withholding responsibility in respect of the notes, we intend to so withhold.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">You should read carefully the discussion
under &ldquo;United States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying
product supplement and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement. You should also consult your
tax adviser regarding the U.S. federal tax consequences of an investment in the notes, as well as tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #00D581; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>
</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">


</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Hypothetical Examples </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Hypothetical terms only. Actual terms may vary.
See the cover page for actual offering terms.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below illustrate the hypothetical payment upon automatic
call or at maturity for a $10.00 stated principal amount note with the following assumptions* (the actual terms of the notes are listed
on the cover page of this pricing supplement; amounts may have been rounded for ease of reference):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Stated Principal Amount: $10</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Term: 3 years, unless earlier automatically called</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Initial Underlying Levels: For each Underlying, 100.00</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Contingent Coupon Rate: 9.40% per annum (or 2.35% per quarter)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Quarterly Contingent Coupon Payment: $0.235 per quarter per note</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Valuation Dates: Quarterly, automatically callable after approximately three months, as set forth on page PS-6 of this pricing supplement</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Coupon Barriers: For each Underlying, 70.00 (which, with respect to each Underlying, is 70% of its hypothetical initial
underlying level)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Downside Thresholds: For each Underlying, 70.00 (which, with respect to each Underlying, is 70% of its hypothetical initial
underlying level)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">*<FONT STYLE="background-color: white"><I>The hypothetical contingent
coupon rate may not represent the actual contingent coupon rate. The actual contingent coupon rate is listed on the cover page of this
pricing supplement. In addition, the examples below are based on the above hypothetical values and do not reflect the actual initial underlying
levels, coupon barriers or downside thresholds of the underlyings. For the actual initial underlying level, coupon barrier and downside
threshold of each underlying, see the cover page of this pricing supplement. We have used these hypothetical values, rather than the actual
values, to simplify the calculations and aid understanding of how the securities work. However, you should understand that any actual
payments on the securities will be calculated based on the actual initial underlying level, coupon barrier and downside threshold of each
underlying, and not on the hypothetical values indicated above.</I></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 1 &mdash; Notes are automatically called on the second valuation
date.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
    <TD COLSPAN="4" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Closing Level of the Underlying</B></FONT></TD>
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Payment (per note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Russell 2000<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>S&amp;P 500<SUP>&reg;</SUP> Index</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">First Valuation Date</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">90.00 <FONT STYLE="background-color: white">(<B>at or above</B> coupon barrier; below initial underlying level)*</FONT></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">110.000 <FONT STYLE="background-color: white">(<B>at or above</B> coupon barrier and initial underlying level)</FONT></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">120.00 <FONT STYLE="background-color: white">(<B>at or above</B> coupon barrier and initial underlying level)</FONT></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$0.235 (contingent coupon &mdash; not called)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">Second Valuation Date</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">110.00 (<B>at or above</B> coupon barrier and initial underlying level)*</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">120.000 (<B>at or above</B> coupon barrier and initial underlying level)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">115.00 (<B>at or above</B> coupon barrier and initial underlying level)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">$10.235 (settlement amount)</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 14%">&nbsp;</TD>
    <TD STYLE="width: 23%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 21%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 21%">&nbsp;</TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 16%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 23%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 19%; text-align: right"><FONT STYLE="font-size: 10pt"><B>Total Payment:</B></FONT></TD>
    <TD STYLE="width: 18%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 24%; text-align: center"><FONT STYLE="font-size: 10pt">$10.47 (4.70% total return)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Denotes least performing underlying for the applicable valuation date</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The least performing underlying on the first valuation date closes above
its respective coupon barrier on that valuation date and therefore a contingent coupon is paid on the first coupon payment date. On the
second valuation date, the least performing underlying on the second valuation date closes above its initial underlying level, and the
notes are automatically called on the related coupon payment date. You will receive on the coupon payment date a total of $10.235 per
note, reflecting the $10.00 stated principal amount <I>plus</I> the applicable contingent coupon. When added to the total contingent coupon
payments of $0.235 received in respect of the prior valuation dates, you would have been paid a total of $10.47 per note for a total return
of 4.70% on the notes. No further amount would be owed to you under the notes, and you would not participate in the appreciation of the
underlyings.
</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2 &mdash; Notes are NOT automatically called and the final
underlying level of the least performing underlying on the final valuation date is at or above its downside threshold. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Closing Level of the Underlying</B></FONT></TD>
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Payment (per note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Russell 2000<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>S&amp;P 500<SUP>&reg;</SUP> Index</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 16%; text-align: center"><FONT STYLE="font-size: 10pt">First Valuation Date</FONT></TD>
    <TD STYLE="width: 21%; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">90.00 (<B>at or above</B> coupon barrier; below initial underlying level) </FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">80.000 (<B>at or above</B> coupon barrier; below initial underlying level)*</FONT></TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">85.00 (<B>at or above</B> coupon barrier; below initial underlying level) </FONT></TD>
    <TD STYLE="width: 18%; text-align: center"><FONT STYLE="font-size: 10pt">$0.235 (contingent coupon &mdash; not called)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Second to Eleventh Valuation Dates</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">various (<B>all at or above</B> coupon barrier; <B>all below </B>initial underlying level)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">various (<B>all below </B>coupon barrier and initial underlying level)*</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">various (<B>all at or above</B> coupon barrier; <B>all below </B>initial underlying level)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$0.00 (not called)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Final Valuation Date</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">95.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">90.000 (<B>at or above</B> downside threshold)*</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">95.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$10.235</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 16%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 24%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 23%; text-align: right"><FONT STYLE="font-size: 10pt"><B>Total Payment:</B></FONT></TD>
    <TD STYLE="width: 17%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt">$10.47 (4.70% total return)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Denotes least performing underlying for the applicable valuation date(s)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The least performing underlying on the first valuation date closes above
its respective coupon barrier on that valuation date and therefore a contingent coupon is paid on the first coupon payment date. On each
of the second to eleventh valuation dates, the least performing underlying on that valuation date closes below its respective coupon barrier.
Therefore, no contingent coupon is paid on any related coupon payment date. On the final valuation date, the least performing underlying
on the final valuation date closes at or above its downside threshold. Therefore, at maturity, you would receive a total of $10.235 per
note, reflecting the $10.00 stated principal amount <I>plus</I> the applicable contingent coupon. When added to the total contingent coupon
payments of $0.235 received in respect of the prior valuation dates, you would have been paid a total of $10.47 per note for a total return
of 4.70% on the notes over three years.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 3 &mdash; Notes are NOT automatically called and the final
underlying level of the least performing underlying on the final valuation date is below its downside threshold.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Closing Level of the Underlying</B></FONT></TD>
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Payment (per note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Russell 2000<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>S&amp;P 500<SUP>&reg;</SUP> Index</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 16%; text-align: center"><FONT STYLE="font-size: 10pt">First Valuation Date</FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">70.00 (<B>at or above</B> coupon barrier; below initial underlying level)</FONT></TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">50.000 (<B>below</B> coupon barrier and initial underlying level)*</FONT></TD>
    <TD STYLE="width: 21%; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">80.00 (<B>at or above</B> coupon barrier; below initial underlying level)</FONT></TD>
    <TD STYLE="width: 18%; text-align: center"><FONT STYLE="font-size: 10pt">$0.00 (not called)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Second to Eleventh Valuation Dates</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Various (<B>all below</B> coupon barrier and initial underlying level)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Various (<B>all below</B> coupon barrier and initial underlying level)*</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Various (<B>all below</B> coupon barrier and initial underlying level)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$0.00 (not called)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Final Valuation Date</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">80.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">30.000 (<B>below</B> downside threshold)*</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">75.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$10.00 &times; [1 + underlying return of the least
    performing underlying on the final valuation date] =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$10.00 &times; [1 + -70.00%] =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$10.00 &times; 0.30 =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$3.00 (payment at maturity)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 17%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 24%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 27%; text-align: right"><FONT STYLE="font-size: 10pt"><B>Total Payment:</B></FONT></TD>
    <TD STYLE="width: 15%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: center"><FONT STYLE="font-size: 10pt">$3.00 (-70.00% total return)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Denotes least performing underlying for the applicable valuation date(s)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The least performing underlying on each valuation date closes below
its coupon barrier, and as a result no contingent coupon is paid on any coupon payment date during the term of the notes. On the final
valuation date, the least performing underlying on the final valuation date closes below its downside threshold. Therefore, at maturity,
investors are exposed to the downside performance of the least performing underlying and you will receive $3.00 per note, which reflects
the percentage decrease of the least performing underlying on the final valuation date from the trade date to the final valuation date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; border-top: #788D41 3pt solid; border-bottom: #788D41 3pt solid">The
Nasdaq-100 Index<SUP>&reg;</SUP></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Nasdaq-100 Index<SUP>&reg;</SUP> is a modified market capitalization-weighted
index of stocks of the 100 largest non-financial companies listed on The Nasdaq Stock Market. All stocks included in the Nasdaq-100 Index<SUP>&reg;</SUP>
are traded on a major U.S. exchange. The Nasdaq-100 Index<SUP>&reg; </SUP>was developed by The Nasdaq Stock Market, Inc. and is calculated,
maintained and published by The Nasdaq, Inc. The Nasdaq-100 Index<SUP>&reg;</SUP> is reported by Bloomberg L.P. under the ticker symbol
&ldquo;NDX.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&ldquo;Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; is a trademark of The
Nasdaq, Inc. and has been licensed for use by Citigroup Inc. and its affiliates. For more information, see &ldquo;Equity Index Descriptions&mdash;The
Nasdaq-100 Index<SUP>&reg;</SUP>&mdash;License Agreement&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white">Please refer to the section &ldquo;Equity Index
Descriptions&mdash;The Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; in the accompanying underlying supplement for important disclosures regarding
the Nasdaq-100 Index<SUP>&reg;</SUP>, including information concerning its composition and calculation and certain risks that are associated
with an investment linked to the Nasdaq-100 Index<SUP>&reg;</SUP>.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><I>The graph below illustrates
the performance of the </I></B></FONT><B><I>Nasdaq-100 Index<SUP>&reg;</SUP> <FONT STYLE="background-color: white">from January 2, 2015
to October 28, 2025. The closing level of the Nasdaq-100 Index<SUP>&reg;</SUP> on October 28, 2025 was 26,012.16. </FONT>We obtained the
closing levels of the Nasdaq-100 Index<SUP>&reg;</SUP> from Bloomberg, and we have not participated in the preparation of or verified
such information. The historical closing levels of the Nasdaq-100 Index<SUP>&reg;</SUP> should not be taken as an indication of future
performance and no assurance can be given as to the final underlying level or any future closing level of the Nasdaq-100 Index<SUP>&reg;</SUP>.
We cannot give you assurance that the performance of the Nasdaq-100 Index<SUP>&reg;</SUP> will result in a positive return on your initial
investment and you could lose a significant portion or all of the stated principal amount at maturity.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_007.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; color: white; border-top: #788D41 3pt solid; border-bottom: #788D41 3pt solid"><FONT STYLE="background-color: #788D41"><B>The
Russell 2000<SUP>&reg;</SUP> Index</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Russell 2000<SUP>&reg;</SUP> Index is designed to track the performance
of the small capitalization segment of the U.S. equity market. All stocks included in the Russell 2000<SUP>&reg;</SUP> Index are traded
on a major U.S. exchange. It is calculated and maintained by FTSE Russell, a subsidiary of London Stock Exchange Group. The Russell 2000<SUP>&reg;</SUP>
Index is reported by Bloomberg L.P. under the ticker symbol &ldquo;RTY.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&ldquo;Russell 2000<SUP>&reg;</SUP> Index&rdquo; is a trademark of FTSE
Russell and has been licensed for use by Citigroup Inc. and its affiliates. For more information, see &ldquo;Equity Index Descriptions&mdash;The
Russell Indices&mdash;Disclaimers&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;The
Russell Indices&rdquo; in the accompanying underlying supplement for important disclosures regarding the Russell 2000<SUP>&reg;</SUP>
Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>The graph below illustrates the performance of the Russell 2000<SUP>&reg;</SUP>
Index from January 2, 2015 to October 28, 2025. The closing level of the Russell 2000<SUP>&reg;</SUP> Index on October 28, 2025 was 2,506.650.
We obtained the closing levels of the Russell 2000<SUP>&reg;</SUP> Index from Bloomberg, and we have not participated in the preparation
of or verified such information. Currently, whereas the sponsor of the Russell 2000<SUP>&reg;</SUP> Index publishes the official closing
level of the Russell 2000<SUP>&reg;</SUP> Index to six decimal places, Bloomberg reports the closing level to three decimal places. As
a result, the closing level of the Russell 2000<SUP>&reg;</SUP> Index reported by Bloomberg may be lower or higher than the official closing
level of the Russell 2000<SUP>&reg;</SUP> Index published by the sponsor of the Russell 2000<SUP>&reg;</SUP> Index. The historical closing
levels of the Russell 2000<SUP>&reg;</SUP> Index should not be taken as an indication of future performance and no assurance can be given
as to the final underlying level or any future closing level of the Russell 2000<SUP>&reg;</SUP> Index. We cannot give you assurance that
the performance of the Russell 2000<SUP>&reg;</SUP> Index will result in a positive return on your initial investment and you could lose
a significant portion or all of the stated principal amount at maturity.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_008.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; border-top: #788D41 3pt solid; border-bottom: #788D41 3pt solid">The
S&amp;P 500<SUP>&reg;</SUP> Index</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">The S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index
consists of the common stocks of 500 issuers selected to provide a performance benchmark for the large capitalization segment of the U.S.
equity markets. It is calculated and maintained by S&amp;P Dow Jones Indices LLC. The S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index is reported
by Bloomberg L.P. under the ticker symbol &ldquo;SPX.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">&ldquo;Standard &amp; Poor&rsquo;s,&rdquo;
&ldquo;S&amp;P&rdquo; and &ldquo;S&amp;P 500<SUP>&reg;</SUP>&rdquo; are trademarks of Standard &amp; Poor&rsquo;s Financial Services LLC
and have been licensed for use by Citigroup Inc. and its affiliates. For more information, see &ldquo;Equity Index Descriptions&mdash;The
S&amp;P U.S. Indices&mdash;License Agreement&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">Please refer to the section
&ldquo;Equity Index Descriptions&mdash;The S&amp;P U.S. Indices&rdquo; in the accompanying underlying supplement for important disclosures
regarding the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>The graph below illustrates the performance of the S&amp;P 500<SUP>&reg;</SUP>
Index from January 2, 2015 to October 28, 2025. The closing level of the S&amp;P 500<SUP>&reg;</SUP> Index on October 28, 2025 was 6,890.89.
We obtained the closing levels of the S&amp;P 500<SUP>&reg;</SUP> Index from Bloomberg, and we have not participated in the preparation
of or verified such information. The historical closing levels of the S&amp;P 500<SUP>&reg;</SUP> Index should not be taken as an indication
of future performance and no assurance can be given as to the final underlying level or any future closing level of the S&amp;P 500<SUP>&reg;</SUP>
Index. We cannot give you assurance that the performance of the S&amp;P 500<SUP>&reg;</SUP> Index will result in a positive return on
your initial investment and you could lose a significant portion or all of the stated principal amount at maturity.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_009.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; font-size: 10pt; color: white"><FONT STYLE="font-size: 10pt"><B>Correlation of the Underlyings</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following graph sets forth the historical performances of the Nasdaq-100
Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index from January 2, 2015 through October
28, 2025, based on the daily closing levels of the underlyings. For comparison purposes, each underlying has been normalized to have a
closing level of 100.00 on January 2, 2015 by dividing the closing level of that underlying on each day by the closing level of that underlying
on January 2, 2015 and multiplying by 100.00.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We obtained the closing levels used to determine the normalized closing
levels set forth below from Bloomberg, without independent verification. Historical performance of the underlyings should not be taken
as an indication of future performance. Future performance of the underlyings may differ significantly from historical performance, and
no assurance can be given as to the closing levels of the underlyings during the term of the notes, including on any valuation date. Moreover,
any historical correlation between the underlyings is not indicative of the degree of correlation between the underlyings, if any, over
the term of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_010.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE AND CORRELATION BETWEEN THE
UNDERLYINGS IS NOT INDICATIVE OF FUTURE PERFORMANCE OR CORRELATION</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Correlation is a measure of the extent to which two underlyings tend
to increase or decrease at similar times and by similar magnitudes over a given time period. The closer the relationship of the returns
of a pair of underlyings over a given period, the more correlated those underlyings are. Conversely, the less closely related the returns
of a pair of underlyings, the less correlated those underlyings are. Two underlyings may also be inversely correlated, which means that
they tend to move in opposite directions from one another. The graph above illustrates the historical performance of each underlying relative
to the other over the time period shown and provides an indication of how close the performance of each underlying has historically been
to the other underlyings. However, the graph does not provide a precise measure of correlation and there may be relevant aspects of the
historical correlation between the underlyings that cannot be discerned from the graph. Furthermore, regardless of the degree of correlation
between the underlyings in the past, past correlation is not indicative of future correlation, and it is possible that the underlyings
will exhibit significantly lower correlation in the future than they did in the past. We cannot predict the relationship between the underlyings
over the term of the notes. For additional information, see &ldquo;Summary Risk Factors&mdash;You will be subject to risks relating to
the relationship between the underlyings.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The lower (or more negative) the correlation between the underlyings,
the less likely it is that the underlyings will move in the same direction at the same time and, therefore, the greater the potential
for one of the underlyings to close below its coupon barrier or downside threshold on any valuation date or the final valuation date,
respectively. This is because the less correlated the underlyings are, the greater the likelihood that at least one of the underlyings
will decrease in value. However, even if the underlyings have a higher correlation, one or more of the underlyings might close below its
coupon barrier or downside threshold on any valuation date or the final valuation date, respectively, as all of the underlyings may decrease
in value together.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the notes are set, in part, based on expectations about
the correlation between the underlyings as of the trade date. If expectations about the correlation between the underlyings change over
the term of the notes, the value of the notes may be adversely affected, and if the actual correlation between the underlyings proves
to be lower than initially expected, the notes may prove to be riskier than expected on the trade date. The correlation referenced in
setting the terms of the notes is calculated using CGMI&rsquo;s proprietary derivative-pricing model and is not derived from the returns
of the underlyings over the period set forth in the graph above. In addition, factors and inputs other than correlation impact how the
terms of the notes are set and the performance of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-size: 10pt; color: white"><B>United States Federal Tax Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Due to the lack of any controlling legal authority, there is substantial
uncertainty regarding the U.S. federal tax consequences of an investment in the notes. In connection with any information reporting requirements
we may have in respect of the notes under applicable law, we intend (in the absence of an administrative determination or judicial ruling
to the contrary) to treat the notes for U.S. federal income tax purposes as prepaid forward contracts with associated coupon payments
that will be treated as gross income to you at the time received or accrued in accordance with your regular method of tax accounting.
In the opinion of our counsel, Davis Polk &amp; Wardwell LLP, which is based on current market conditions, this treatment of the notes
is reasonable under current law; however, our counsel has advised us that it is unable to conclude affirmatively that this treatment is
more likely than not to be upheld, and that alternative treatments are possible.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the notes is respected and subject to the
discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Any coupon payments on the notes should be taxable as ordinary income to you at the time received or accrued in accordance with your
regular method of accounting for U.S. federal income tax purposes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or exchange of a note (including retirement at maturity), you should recognize capital gain or loss equal to the difference
between the amount realized and your tax basis in the note. For this purpose, the amount realized does not include any coupon paid on
retirement and may not include sale proceeds attributable to an accrued coupon, which may be treated as a coupon payment. Such gain or
loss should be long-term capital gain or loss if you held the note for more than one year.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the notes. An alternative characterization of the notes could materially and adversely affect the tax consequences of ownership and
disposition of the notes, including the timing and character of income recognized. In addition, the U.S. Treasury Department and the IRS
have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo; and
similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance. Furthermore,
members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury regulations
or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment
in the notes, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative tax treatments of the
notes and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Withholding Tax on Non-U.S. Holders. </B>Because significant aspects
of the tax treatment of the notes are uncertain, persons having withholding responsibility in respect of the notes may withhold on any
coupon payment paid to Non-U.S. Holders (as defined in the accompanying product supplement), generally at a rate of 30%. To the extent
that we have (or an affiliate of ours has) withholding responsibility in respect of the notes, we intend to so withhold. In order to claim
an exemption from, or a reduction in, the 30% withholding, you may need to comply with certification requirements to establish that you
are not a U.S. person and are eligible for such an exemption or reduction under an applicable tax treaty. You should consult your tax
adviser regarding the tax treatment of the notes, including the possibility of obtaining a refund of any amounts withheld and the certification
requirement described above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m) of the Code and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S. Underlying Equities&rdquo;) or indices that
include U.S. Underlying Equities. Section 871(m) generally applies to instruments that substantially replicate the economic performance
of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable Treasury regulations. However, the regulations,
as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one.
Based on the terms of the notes and representations provided by us, our counsel is of the opinion that the notes should not be treated
as transactions that have a &ldquo;delta&rdquo; of one within the meaning of the regulations with respect to any U.S. Underlying Equity
and, therefore, should not be subject to withholding tax under Section 871(m).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A determination that the notes are not subject to Section 871(m) is
not binding on the IRS, and the IRS may disagree with this treatment. Moreover, Section 871(m) is complex and its application may depend
on your particular circumstances, including your other transactions. You should consult your tax adviser regarding the potential application
of Section 871(m) to the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We will not be required to pay any additional amounts with respect to
amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement. The preceding discussion, when read in combination with that section,
constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning and disposing
of the notes.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the notes and any tax consequences arising under the laws of any
state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-size: 10pt; color: white"><B>Supplemental Plan of Distribution</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">CGMI, an affiliate of Citigroup
Global Markets Holdings Inc. and the lead agent for the sale of the notes, will receive an underwriting discount of $0.20 for any note
sold in this offering. UBS, as agent for sales of the notes, has agreed to purchase from CGMI, and CGMI has agreed to sell to UBS, all
of the notes sold in this offering for $9.80 per note. UBS proposes to offer the notes to the public at a price of $10.00 per note. UBS
will receive an underwriting discount of $0.20 for each note it sells to the public. The underwriting discount will be received by UBS
and its financial advisors collectively. If all of the notes are not sold at the initial offering price, CGMI may change the public offering
price and other selling terms. For the avoidance of doubt, the underwriting discount will not be rebated if the notes are automatically
called prior to maturity.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; color: white; border-top: #788D41 3pt solid; border-bottom: #788D41 3pt solid"><B>Valuation
of the Notes</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the notes set forth on the cover
page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated an estimated value
for the notes by estimating the value of a hypothetical package of financial instruments that would replicate the payout on the notes,
which consists of a fixed-income bond (the &ldquo;<B>bond component</B>&rdquo;) and one or more derivative instruments underlying the
economic terms of the notes (the &ldquo;<B>derivative component</B>&rdquo;). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the notes prior to maturity will fluctuate
based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">During a temporary adjustment period immediately following issuance
of the notes, the price, if any, at which CGMI would be willing to buy the notes from investors, and the value that will be indicated
for the notes on any account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one or more financial
information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT>
This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the
term of the notes.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT> The amount of this temporary upward adjustment
will decline to zero over the temporary adjustment period.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT> CGMI currently
expects that the temporary adjustment period will be approximately seven months, but the actual length of the temporary adjustment period
may be shortened due to various factors, such as the volume of secondary market purchases of the notes and other factors that cannot be
predicted. However, CGMI is not obligated to buy the notes from investors at any time. See &ldquo;Summary Risk Factors&mdash;The notes
will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; color: white; border-top: #788D41 3pt solid; border-bottom: #788D41 3pt solid"><B>Validity
of the Notes</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Davis Polk &amp; Wardwell LLP, as special products
counsel to Citigroup Global Markets Holdings Inc., when the notes offered by this pricing supplement have been executed and issued by
Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant to the indenture, and delivered against payment therefor,
such notes and the related guarantee of Citigroup Inc. will be valid and binding obligations of Citigroup Global Markets Holdings Inc.
and Citigroup Inc., respectively, enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency
and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability
(including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses
no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed
above. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New York, except that
such counsel expresses no opinion as to the application of state securities or Blue Sky laws to the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In giving this opinion, Davis Polk &amp; Wardwell LLP has assumed the
legal conclusions expressed in the opinions set forth below of Alexia Breuvart, Secretary and General Counsel of Citigroup Global Markets
Holdings Inc., and Karen Wang, Senior Vice President &ndash; Corporate Securities Issuance Legal of Citigroup Inc. In addition, this opinion
is subject to the assumptions set forth in the letter of Davis Polk &amp; Wardwell LLP dated February 14, 2024, which has been filed as
an exhibit to a Current Report on Form 8-K filed by Citigroup Inc. on February 14, 2024, that the indenture has been duly authorized,
executed and delivered by, and is a valid, binding and enforceable agreement of, the trustee and that none of the terms of the notes nor
the issuance and delivery of the notes and the related guarantee, nor the compliance by Citigroup Global Markets Holdings Inc. and Citigroup
Inc. with the terms of the notes and the related guarantee respectively, will result in a violation of any provision of any instrument
or agreement then binding upon Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable, or any restriction imposed by
any court or governmental body having jurisdiction over Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Alexia Breuvart, Secretary and General Counsel of
Citigroup Global Markets Holdings Inc., (i) the terms of the notes offered by this pricing supplement have been duly established under
the indenture and the Board of Directors (or a duly authorized committee thereof) of Citigroup Global Markets Holdings Inc. has duly authorized
the issuance and sale of such notes and such authorization has not been modified or rescinded; (ii) Citigroup Global Markets Holdings
Inc. is validly existing and in good standing under the laws of the State of New York; (iii) the indenture has been duly authorized, executed
and delivered by Citigroup Global Markets Holdings Inc.; and (iv) the execution and delivery of such indenture and of the notes offered
by this pricing supplement by Citigroup Global Markets Holdings Inc., and the performance by Citigroup Global Markets Holdings Inc. of
its obligations thereunder, are within its corporate powers and do not contravene its certificate of incorporation or bylaws or other
constitutive documents. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New
York.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Alexia Breuvart, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Global Markets Holdings Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed
above. In such examination, she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures
(other than those of officers of Citigroup Global Markets Holdings Inc.), the authenticity of all documents submitted to her or such persons
as originals, the conformity to original documents of all documents submitted to her or such persons as certified or photostatic copies
and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Karen Wang, Senior Vice President &ndash; Corporate
Securities Issuance Legal of Citigroup Inc., (i) the Board of Directors (or a duly authorized committee thereof) of Citigroup Inc. has
duly authorized the guarantee of such notes by Citigroup Inc. and such authorization has not been modified or rescinded; (ii) Citigroup
Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture has been duly authorized, executed
and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture, and the performance by Citigroup Inc. of its obligations
thereunder, are within its corporate powers and do not contravene its certificate of incorporation or bylaws or other constitutive documents.
This opinion is given as of the date of this pricing supplement and is limited to the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Karen Wang, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed above. In such examination,
she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures (other than those of officers
of Citigroup Inc.), the authenticity of all documents submitted to her or such persons as originals, the conformity to original documents
of all documents submitted to her or such persons as certified or photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>&copy;</SUP> 2025 Citigroup Global Markets Inc. All rights reserved.
Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout
the world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->



























<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp236486_exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.0a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ef306dff5cd0f9a8e13ce7fb8967ac96 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024">
<head>
  <title>Filing Fees</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="ixv-211">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="ixv-212">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="ixv-213">0000831001</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="ixv-214">333-270327</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-30</xbrli:startDate>
          <xbrli:endDate>2025-10-30</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-30</xbrli:startDate>
          <xbrli:endDate>2025-10-30</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-30</xbrli:startDate>
          <xbrli:endDate>2025-10-30</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: right; font-weight: bold">Ex-Filing Fees</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold">CALCULATION OF FILING FEE TABLES</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="ixv-248">S-3</ix:nonNumeric></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; text-align: center; font-weight: bold">Citigroup Global Markets Holdings Inc.</p>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="ixv-249">Citigroup Inc</ix:nonNumeric>., as Guarantor</p>

<p style="border-top: Gray 3pt double; font-size: 11pt; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="ixv-250">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-251">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="ixv-253">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-254">470,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-255">10</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-256">4,700,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-257">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-258">649.07</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="ixv-259">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-260">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="ixv-262">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-263">0</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-264">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-265">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-266">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-267">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-268">4,700,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
 <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-269">649.07</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-270">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-271">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-272">649.07</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-weight: bold; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ix:nonNumeric></td></tr>
  </table>

<p style="border-top: Gray 3pt double; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-275">4,700,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-276">The
prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  0 !0# 2(  A$! Q$!_\0
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8 D\K,(1@#:,GGIUZX ':@#IZ*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_007.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M3:YRE\O<YCKWN="-KG.'0882F$ ,KB2!-*@QC&R$8J(7@4<W=D:-7J0"%&7
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ME&C&_L>09/K\IQ:>_P&%*WM"$6;#< !A"!Y%#KE&,00X0 (6T( '1& "%;A
M!C;0@0^$8 0E.$$*5M""%\1@!C6X0?\.)C :\8G)!=9PC )>(PTOZ8(V.KA
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M UDH F_P G!<DYW#S?(T"7C8M9B@K(CHA9<0@8:CB&:)B008!5^$B4J DQ&
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M<(6LB!!L$(9_, ?X^0>'R-1KK8@^(( &L( >.!UXN#L & !O&@F"1 \M>!X
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M"$)+!W@HAFF0!3!HNPAA!V_H!GW0A7'XAEFX!UEHAWVX!7,HAW)X!E%(!UP
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M.&J4%SP8E9#RL1\G4C*1J $*= /WGCWYY0\LRO0 M)!D]M\\<)0R' &3/O\
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MP,,;X""&-;B!#Y_CU22,5 C$SJ,?]\A%+P8ACW*,XA6U((@P=G&*4J"L'NH
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MYV)7RT#&/X;QBG9\AQR@6 <E_U&+%QL#+L[ !32"TPY0*J0;HJ0VP"7#"=K
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MX'% 8EQCP="8FSN\P=)P! .]_R@',+ QI'A Y!W>."XY3 ,%?9CYJ5XMI!
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MPSAD'C>D0CB, C38 WVX13*@ CF@PC:H@RJH@S=PB;; WC*NUS T#6D401Z
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M/#B#;UJ%'6@#,MB#FLJ;&?PN3#S"/Z##'4QE"( N>3!"(7Q#,G@B2CR"4=P
M+*_Q^G)G2\3#(U[#9U+#*]0#L)D#*.Q#O-4"M#"#&V*#*%##.=(#O_V#OS4G
M-73!%FR3/7#.%&L$/NS"W_Z&#+SO+JBH&#< ^RB$(M#O44B (SP@,S#_ 4Q@
M0.)RQ27(5G7:\IE%KE;(PK)I',>! C:!Q\>%'2V,'7N8W<G-!"J<PCRX T,W
MM$,_-$1'M$1/-$57M$5?-$9GM$:[PSR@@Y?"1!8H@&PQP++90__"A ,$H0\
M 1=,PSV0 T.K T%9Q0B@D@40@S[, SA@0X-8A92Q T.30SD8 DP$0#\L-$//
M U)O-$3/0SOD+ !P@3XP-557M55?-59GM59O-5=W-43/PM4.13J PO9DW4MA
M0V1XW4S:E-BIARZ4W=F] R   J8X@UW?-5[GM5[O-5_WM5__-6 'MF /-F%S
M@R'\0(=T@1A0@?7PKV,20"I4PS<0 UYK2H<T_T OO*,RD%!1!P #X$)=VW7;
M" !,3$)H$_9?1P,V$ \ K( VH#9LQ[9LSS9MU[9MWS9NYS9A+X-?288]Y$*"
M7<,RY4/E41$[9-[F!<V+,4,U)H,U# .7<.3R/.(R\@/J=(@ OP8.3 (:H$'S
M=D0Z> (-O<8%2  ^< /WPH07X -[>\08!$$:;*ADG((38 $BV/.9B2I78*1"
MJ(,TA,,NJ$(@$,XLD (KN*$RQ,(JF$+S'34HO,(@[ ,ZA$(H! *?07 !?C3P
M*H 59$(&B\2X_(8GF"=,-, 3\!E^VV@;=X0Y',?[_8,^7(,BL4,T+!H /P-T
MN(,E\4,P0(LY+ ,M*O^Q).)"$3@F\*;!$=KO:U@ %!R% CAHBIOHBH-$!3JO
M)+J#*(""S![%$00!3%C )B #"L!&)*3$,&!"GQR% Y"V<,YQE*LX+B\.AA^<
M,RC!++T& U"#+ , !:3'#;P&(S@C2I # DK 5 * &:#;FVOIE&]$/7!#Q%11
M-,PX,)A'.21#,Z0A/SB#CV-#D,TYP)G"2;^&(/R#'\"$!Q@-*%0*3*S!*=3R
M21B#'FQ"+!SNHQ1"#B\ZG$L&-,A"+WSNA=""+@!"-GS,*1C",ED#*-""+!R0
M.O#"*P!"/:"#+X1"(7@;)-*@.9!"1:GK#]0!%\L7 -220O2"'K1!<FL%^OC_
MB:XC:J,C$"K @S]L \0%@RY*@R[D [#=PS 7\Q$=PUQP@R@,P]SX0RQ8Q+9D
M'P$-23W0PAEP@R*\@%4T@ 04  ?@V25E AM<,654 ZL#P *WNY;B<TN$@R6$
MPBXP0_ALG#7YL\>MM<@1M#<8M#AU22_X LNBK,[O/,_WO,__/- 'O= //=$7
MO<[K0SSPPRP00SJPPSBX ;>M@!4(\$,=A2:T0CWT0C&XPU2C;"&!PSWL/$<;
M/=E[.4Q( MFGO=JO/=NWO=N_/=S'O=S//=W7/<J"-5>,0R=$S"Y@&<MO'5HK
MA/7-9"P,X$"[-5R_AT+L0R54 C!$ ^1'ON1//N57_[[E7S[F9[[F;S[GVS T
M/ ,*<   6  9M,*?3T\&&  '*,,P/$,V) ,W3#XVQ'[GU_[D-X,F=@$RT+[M
M][[O_S[P![_P#S_Q%[_Q'S_R<[XSY"M7@$,N#,DI!-/#_D,_S&G^A(,NK$-R
MAX(#&<-<-(,P4 .7:/]T3YLU5(&:L[FCQ$ TT(.D#<Q,FY[(FZA^:X4VG((N
M]$(XQ ,TA(,OW ) &,KW#]6N0=S^3:L5J]4_>/;TQ0HU:%TY5:0"#?NWT9JL
MC1]!AA0YDF1)DR=1IE2Y\=06!P!@QI0Y4T$' !A2K=2Y4^0E.4**\10ZE&A1
MHT>1)E6ZE&E3D:+<.;6G+?_=/VD-QT6CMS&=-FD?JQ$K]\\=OW_JG*W;" [;
MP(\=G<:56Y+73+L Y"RR(B0&EV'&0!&;.YAP8<.'$2=6/!CJ8'UNF<)=/!FE
M-E!E9J&*,O.%EY<P.63[N(]R:=.G4:=67;KQZI6272MFMDA*@[L+<.  ]B]8
M%P$W.L46/IQX<>.G6Q\7"5NY4W1F[LH\)1):<^O7L6?7OC&YTFV(6+&*]U%8
M(%7W_FT;1.O=OWJV>&G<6 Y7H%Y5KP4ZI>^MQ^U'X9$#A^AB,N*_ Q%,4$'%
MND.J'%>(2<<<=#;"YQ9^9FF%G%/H"884<%[Y!AI6T/N'&%?4N>4:=4[9IY51
M/O+_II<%=R(GDQ%F4L$01N0P)!,S&J)1R"&)+!(E7*):2IQ)8GFEO8U@<>:?
M>'8AYI>-;)'&EXU6D6<C533"1Y9EA/D'G$#6&F67>/AIT\TWX8Q3SCGIK--.
M.,<Y9QQRR &GG!*W4<4=<<YZ)Q$@4+!+AF_^*<><?\2Y1YRR[JS4TDLQS533
M33GMU--/00U5U%%)+7747N9A2IQ6I+$G%'B^G.8L6Z)Y92-!B!EDH_@VJJ6:
M?RRT!I=_PCEDHWT*J008;)AMUMEGH8TV6FV@D>:99X9)9IMMM9'66VBY&<:4
M1THQQIA;MA#!"208 &"#28:00 &[,*"!DFNJP8:;9??]_];??P$.6."!"2[8
MX(,13ECAA1ENV.&'(98V&E_&86JL+X/ZIQ0IYPF%&%@VRD6>Z?XAQ9Z-=*'F
MGWQ2(9/86CXJ!I7"6AGVGVM@50J9&#(@H((*)KBKW;M8Z"95(Y%.6FFD34E2
MJ71.Z6<?5?Q!1YQZ5%FGE&#,4:6=:V!AIY=DJ D%G'/8R684?D8AIF-_C&&F
MOZ*6 0206L A21XI8/)AA0 &V$#P/XJBYY,,"$P<IB-(6]KQQR'7KD&DZ#EE
ME9/E,28A062IJII <HG*'_A.MH?18P2!A4)L!#%[;I.>X>.,?OY!9 U0< =%
MAYAVR&&3>D+R(7$A2KI&#T% H?^%PI"D@2'Q)8H(X:XV=%&EJLBQSU[[U29G
M"AYLG(+MF5=N"2,7/2R!1@N8%A!!<9C6^,<?=?Z9Y8/$/;!%)&.<F#>F8WXA
M @&*H X_D(D/#*&*SWQB(_0@ 4P2$(02=&$KV[/@!3%XF.XMY1SA"%]#X($/
M_\E$ (A[GTQH8 <:Q" %=[G 3!Y0C)/]0Q5"N$L$+! ="?#A8LNH!"U X@Y
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MTD9"$:8QE>E,'YG&3!8PD&/L(Q_R20D^!F 7 T!&)'>XBP.20+N0R*.(*XO
M [Q #GNNE*5(;!I3P%$*<I@#9K&:5:UNE:M=R<=7P+J%L(AE_ZQ_K ,3 '
M!) @AU3HBQK-2$8UN!$-J4Y5JLR:*C<N$9,'",$#%Y##-JA*56YLPPI;6$!,
M%*"&:"2#JMK01C*($=5H#,(7UP!&6/&:5[WNE:]]]>M? 1M8P0Z6L(4U[&$1
MFUC%+I:QC77L8_7J#(HQ!1>6T$4AQ) D47!,%<D V3]V,;*-W$*DK]!(/_Y9
MIG" 8B/L>,496D&_?]S#'>JP[6UQFUO<NL,=5'AA&<+ACU*\0Q^ZO2TYT%&.
M7,2$#N@8AW%WFPYVD .ZU;7N=;&;7>UNE[O=]>YWP1M>\8Z7O.4U[WG1FU[T
MSB*122&'/*B!#$JP QWG:$<H_/&+9?_<(Q3]F$8IV#&+;50C%.%(1SB&X8IW
MO"(9^KA%.UJ!C!C9+"G,2$6)=$($)I!!<RWU\(=5B:2XD*-,F;N9(7IQ#DW2
M-57O (4M!F(/T1C#$**@$# "H0L/<F2.(/;QCX&\%'P:!1X(:0IS@IQD)2_Y
M)$,NBCC8$;X>,YG*55:RDV.#9"MOF<LLQ?)*\)&+4\P3=9/EAB!L441\#,(0
M@MD(.E(A"%U$V1N"H(5L_Z'E+N^9SVW\<DK208IU)(.U&Y&&*LA1"ESH@Q3\
MX(8O[O$*>>0CF!MY1B_,\8IB\.,6\["&*U[79U&/&HE_1DDYRJ&.4%#XGU/*
M13.N] ];$)3_2U[Z1RA49@]97(.A:-K(-&9!:F$/6WLO;<HV=L&,':M"5NJ@
ME:W^@2M=_8-7_^AIL(95K(T8"A#86,:WP1UN<8^;W.4V][G1G6YUKYO=[7;W
MN^$=;WG/F][UMO>]\9UO?>^;W^2^QBXJMA1TY.T?N0#?/S9+ELY^=A?X(!EI
M-V+:?Z V&JJ-16M1L9]Y;)SC'??XQT$><I&/G.0E-_G)49YRE:^<Y2UW^<MA
M'G.9SYSF-;?YS7$><E2T%RGIB,4WZD&+>D 9'K>H!RJ< 8Y02*,;HD@'*H#1
M#%6$@QW@@(8NVJ&+:CBX'Z*PQD>Z 2-BCYWL2!.Q]W*Q"GQ8Y1C__W"&(5!!
M*&JP8C]#C44M@"?C?PC#$*88RS,"X8HH\[CLA3>\@DR]$W_LYLA3/OSC(6^<
MQ.L$RE*._.4Q+YS)GT;/F??\YS4X3Z54HQC:G)(R;'V/8+@9'5%5\4?\X0W@
M37(:%LVSXT&?>]T[9?,D$8<P>J&+01QM'*"81262@0Y=O((5FF-&+GRABHNM
M@Q>H (0]Q)&+40A"2H3?_??!_T;1'^4<HC%H]Z?A#6"IPAXS8\<>0[$14.3,
M%-KXQS-*\8V&[*/0_Y!1^ $P (7B[)I"'+PFXB1)'4 !&_S#$)*AGVI!9?[A
MY_[!5;JA[<(!$#;B'EPA%]9A'T P!$5P!/])L 1-\ 11, 55< 59L 5=\ 5A
M, 9E< 9IL 9M\ 9Q, =U< =YL =-L)CBXAJ>X2-<09+F@1:P0>Q8H1IJ*A:J
MXQ]H033ZX16Z06[8H1".I1 *01NXH0N]\ O!, S%< S)L S-\ S1, W5< W9
ML W=\ WA, [E< [IL [M\ [Q, _U4 RQ8;(L9AN><".P0<+DH13H(=C,01?T
M":',8N^BX?ZZ01J&Q1^@K9!F1@ Q,1-+(K::HA \015"81S<X1L";14,82M@
M 10$81MN9A":[Q_:01K&(19R81#&XQ5H01"^POLTL1=[L?=(PG2:81O8 1_:
M#ARV02T@I1H@ QK_)+"X)ND9DH0=FB%G>-$7L3$ @1$ER*&"(@/WLC$<06\;
M)Z/SQ/$<+X\<1V(?!F\CUD$8)- <E&$((<49KJ$=8=$:1,H=NN%70@T= 1+S
MU!$DT"$9W, :R0$44J$0F@$=5$$6;($9RN$83N$60F%Y]H$78 $0\.$<<F$6
M#.$:_C$@2?+P!O(CB.$5$@$RE$$9)H[]9B8=X&\C8B%G<&$(MP$6JJ'M^*'_
ME&%&2C(H#8\ E2)O>&&&_D'3SF(!&S 9>*%7)) "+; A,G #7V$5]N$=M'(K
MN;(KO?(KP3(LQ7(LR;(LS?(LT3(MU7(MV;(MW?(MX3(NY7(NZ;(N[?(N_[_2
M'X#0*0(!*5U!)(^0&X!R"6N*%IYP%:3P%;S!"@G!'06!$+;!K21S,BFS,BWS
M,C$S,S5S,SFS,SWS,T$S-$5S-$FS-$WS-%$S-55S-5FS-5WS,H'A%%3**01A
M[3:"&S0'&D0!'H*-'%Y!G\8B%,;C'[I!2H#!&^1!%/Z!'D!M(V1&**&3[#C1
M*7B!=O8A&=+A%FC!$&"E%&I!$)K![0*!%;XN%L>!%E:!%>A'%F*A-D<R.N&3
MSTX2),:!4*1!;L*A&H83':C!&^W!UD3Q'\9AZS;B'+ZA<:XQ/A64R^93)+K1
M\A8T0K>L00W#'"7T0D&,0@O#0C&T0U=*0W5"'O\"P1!8<2/$819:QX.$@1!B
M83AOST-AU,= 5"7 017Z@1Y8(>"T 17 01:F81U"T1LJD4-CM$C];/P2@QY6
M@4MV\18TPA[^\NO P1 ^0AERPDBQE)ZFDS+Z@4JIC:=^)5A,(:BV#1#>('?0
M%'<&08_2%$U9P1#:%$T)P1;B-'<$@1?J],4((4]!P1!8(4]K84_Y5%#KE,T&
MM1;X]$[SU!:0)T\5M4YM@5#K5%+;-!#8=%(1M5#A-$]YH5'K]%'CE%'Y-%#Y
M-! &@4_7]%#S]$T'E4X=%4\AE5+3U$\!55;3U%9SQU#SE! R-4Y9=5$]-4Y!
MM4TCE4]! 5=QQU)555/_^;1308$7'"'@*,,?"@KB_L$53@L6*HY8+NX?TH$;
MO"$>WL$?R-4?]F$=_,$:D$$=T+5<_6$=QM491$%<W?4=VM45Y($?W)5<WT%?
M4:$9^&%<W?4#J0%%]F%?^]4?1 $;Z+5>^<%5U*%AR74?]-4?3J$>]M4?^ %=
MO:$4,O8=Z)44I.%CZ?45FB%CS34>DD$6V#5C-[87MD%B)S8>KJYE$38>Z.$6
MV"1CUT$=O$$89-8?^E4=7N%=,W8?XL$9CB%H4]9*XN%@'58=4"$;VG5?UP$:
M1L%FZQ5G?Q-J!S8>D"$8*A9EFPYER_44Y,%L_6$94$%M_2$4L@%E038>>H$;
M_]Y58,FU9^7A%H2V:H4V'M3A%X+A;@=6'=J!%/H69>%!E\9V7Y7A&-3!:_<U
M%.JA<=W5&5 A8O'678E!%_QV7T<!&"377:'A%C[77=NA13:7<*T!:#<7!(66
M:C[77OU!&4Q!'2P77OU!&WY!'=X!21/C'&8A&K1!%=@A'.[AT/HA%+XAE^0!
M%H0A'<9"'*3!&S]B^OK!]/YA>:QB]@AR(QYV-D."/_0!'UST(\ZA*OI!I,9W
MMN1!&4-"I=BA'_@H)#!L)':L)+17)/8W),J!C^:A'U ))/C!@S!V)&!E'/H!
M'S\"5L(A>T7B'/*!'N"A$4-B'?+!']J!>Z\W']H!'O\0-"3JH1W(=23,H1^@
MP1Y>+R38P1Z@(1\(+B3VH1_Z<R3$(1^D01ZD537>P7LY>"/Z07POYB/X 3*&
M^"/ZP6E^^"/FMW_=D:-"0ASZ@3]*HAW.]S26)QVDP1JO=R/@H1]BN(NG)(A#
M@GLG337X(>VVHA\T0AE802)-A!=2+!/<@1QVX1,^H12NASBQD!@@X1$.00(W
MHA/R(1Q4X1$^810P3!LPX1^H 1$> 1'\\2-.01"HH1$^@1/:[B/HP1*T818R
MX1$ @7WK1Q%@Z1,ZX1<X6!@(&1 0>>H^ AGR !2X(80_0@THX1;H@>?^ 1OD
M@!>"X1T&&(GE0!"0X1T8&!;_28$1IN$0'@$32JI1L $1=J$5-$$24&&(%XP3
MZNP1&L$V-V(>8*$3C"$6'J$3)KD"0:$3JD .U(!DYJ,; $$2C@ ,U& 7&R@7
M(N$.BL .GA(DXB$4'.$/AH .% $?=6$34#D2*H'"N",3.*$3.J$2@NTCUD$1
M.@&5%4$0 (F.-B&B)_H5AID<YH%?X0$>VO$<R@(>QA4>SI>D31H>\A<=W"$>
M6-H?X %^0V8,(H$]_N$3P#D?P. 1(.'KB*&1B5 ,.@'&_F$22O0?WL$2-L$1
M6J$<ZB$X0"(8$$$92&$3T!DDV($7:N$9.D$28B&,M0$1K&$4).$1[ \DH $1
M<,$4_^(@$]0O1AHA$ [!$8Q $0X.4A0!$"KA$-) #PRA';DA$@;A$"Y!""#A
MKC<"&CI!KQ-A"/(8)#0A'-0A%E#Y& 88%YX2&!SA$2K!U@01$?YA&"8ADCOZ
M'Q;A&\YA%#[A$1 M.\:@X,;I'P[A$O\!%XS%#@A%']9@@-T '%*AT&JAH'@C
M.-X@5<2A#*@8%L/@']Q@%\? M"<!%H8A#C:B&RCA(^;!#_Y!$Q[Q'^S@K3?"
M#]!!$:ZT$\9T(T8!$?)($A0A$6)M(]: &V"!$28:$+R7&1YA&VR!$B;A$)IS
M(X@!#(@A%S(!$@!A%[@W$MIN#,(3%ARA@<6@E]4 O_$Y$?]LA0ZZ@3<V 20J
MV;7'21XV_"/L@#3801+"@1*^;B-: :EEX13P(<4WPA.J QTH01\6@;?_(1(R
MAA/LP19JRI'_('_O 0WJ]RSZ()'.P0_<[!\&X1) @AG<X"/2 0V\L1S&0%8^
M0A"&@!,R(1,H01+ >1^(@ PZH<PEH9\VPA>TH,W-7!*2X2/T00[2@,PS01*P
M\"/:(0T0W!;J01,L"A*6U!Q081:PX1' VPQ4C!IJP1X8H;S_(1 2P5M+01>^
MX0Q 0AD>81KT@!3D)WX^8A%Z01:>(&\.88ZV01**80P$X1_,80SVN!_B0!DD
M@8'^80P05!FJ8!*4E@B4P1O1H1/_S  5N($.*&$9!O@9L* 1EJ$8N, 82+D?
M\D 3@L$9JF 4;"_# ^&S%D%N-L(56,&\MRW+JS02_N$-*B8=RD";SN =NJ$Q
M;^W<L8,-1&$1GA(<,&&3%4D.FB$-HF(8/(%[]^ 6"$$1O)40@/(?@"$*GF$.
M!J(=SD";U*$3XCH4[@$8XJ#)2P$4AL$.I($<!J%;9XL1JL$0:N$>FB$.P/D?
M% $80@$1Q@$:- &]9>'/@849Z'$CQF XTV$9F '/CH'=-Z(>F,'2380.1@,9
MBF&(!R$5XH$.D.$>:&':ID02^,$:XH ?]L$-O-$7;D$=* $5[D$6K/PC!,D=
M)H$6[D$8_QQ=Q;WA'N2!#L*A$UQR([P!#/;A'G@A:L  LTOA'H1:'Q#AOO_!
M$7;A'OPA#OHA%H!H(]IA#Z3A'C"_&?@ S\B!#(@!\^]A&/@ G%^A$]P!\\<A
M%Q8!?<5@OS!?'N#@SM&W$$B=)*#!$VSY(]#A[JK8$Y#R@C.A?LV!%)0 ,D(A
M%U )&/Q@\#=B'#)A]L)A%)8@//TI$ :/&-1 #T!"&#@!'9Q!&\K!&9S^(RCA
M$4'-'#I!.3="&R2!&H.B&M1@A?OA#?2A']HN'^!@GL!A%4A!'SQ=) ""6R)J
MNF3].XCPW"U:YLX@?/AO%*MYDM1!I,)LDZ]_XR(50_BK3[,YX__^;:/T,%J1
M9W/H_<MW!AS"-:QH<?HGKA8IB#Q[^OP)-"C0;:DT/?IG2E4YA/=:W3+C#-VA
M? ^_I>KD4-DJ<0C9&7N%AMF_2MD@\IOE*4H<0.T@;JO51D^D5$L1SH.UB4B<
M2_@@@COFB @=3,0>NGL'M%^ZG^1<_@17#R@[9)&D&3J32R9"?I5>;:-#:=O#
M<\$Z98MUAE5)A.BV=7KFZDPB=P_W.3H3Z5VT:!"/G3GCZEXJ?@_5*3KSJ%ZS
M:>@>C@MT1E(U><P6(Y2FRY$E2:K\0>PW:I(F3[OZC;X&ZM,93,;./6R'2I&D
M.+&D]6S[,YYFGY%_ZB/W4SVP(#1.)O/_(%0.+O8@Y$HN#ZTS2U>;.'80,M\@
M9(H@$+VBS$'J,++/@X6X]T\IJT#TBRD'W;/(@@]Y\\I!Y5RB34_+>'*'3^RH
M8H4N/CW3"1$_R7.($!8]I UEBOR#2BD/D8-,*F%4$\XA^CS$CC"FB-'-6/@=
M!(TQ@<3Q#S>Q"(5FFFJNR6:;;KX)9YQRSDEGG6R*\LMJ[; #D3&C$/>//ZL=
MM,\HP<A(U4/*R +/0>L<^- UL,AS$#WK&/8+,NZA TU=!W$#2UG_O-,H@:4<
MHQDT7#TDRBR0KA/.0_VXXLQ!Z"#V$#.R7/J/.O<\Y(\LTR#DW4/ZC(),7>:E
MY(I]O0)Z$#BC_YAB73Z>_E/.+WD>5(]U!R4C2S;\ ./.L@>) PLL]VBSCS3[
M_0.-*\WH@\TX?3U$#ZW@.',/-! YDTJQZQQY4#BI?'20BP_!HNE!_:P*)BK^
M_D-.J79>_!,PQIA22KJPQ$.@*<9TG.ZA"!%C3"LDPU+L/^$<8XPH)'?)FC7(
MR-SQ,23^T\\QS)0"-"S#O(@,+D'C$BM"SFP<]"]7'N2.*<QX_$NM"&FS,=70
MCB,RU0@?E(XQ(Z?[BS6>2L/,,; $3:FM-HNR-BPZ(Y2/SVMW+*JCK1AS-RPU
M*HT,QQY#^L\\(J]L]4%8J^PQKP=E8\PQ*_?W#SB:8.*+(36.0;DXC?]P<HH@
M'<:!#4+/\)$++[3$@X\:" )"R2Z&B-6)6 CE D8N@J#RCR&G(/2.&I70$DA?
M9.SLRAJZOR(.*8;818<BNE?S3QBT@?W((J$O\X\:U" 4#!^[#)++/,]8@I X
MCG3BBR!=2L+;0=O4D3HH_.2SQD/VC#$(**S0PXXP/ 1WNHL0*QQ$*#<,SQ"4
M(@.?#F(.3TQB%X)XQC_$8#%DB"$7@?!1-SZ!D'1THA&A*XP:+G209=!O$*<0
M1S,<@I!A\ $4MHC%/?@AAH>P@CR&<)(B(L0M. 0B%H-HQSD$B!!W@.$2N3!$
M6<CPM'_  @ZR"P4[8($(C&FQ)[Z8PB58 <;_05A,'7E(0RW"R#N$H"(+F.!%
M&._U#W/L00YN9,4@?)0^3W A$&',A;>:H05-V"*,B?L'(XP@B#""PAP/&400
M$@%&.T+K'5C8PQGM*(J'W&(*BHAD$9-HACX,THY +-@:ON#)6S3G(-<(PB?J
M. C1G$L27>"C'7/QP'\D0PN6&.4@N(>0>A !#KY$QD-X$81#>-)Q^Z""'RXY
M""<A)!19Z&08*?</9DQA$;#,&S'X<)!YD,(9GJ#<.M)0,%=<XQ/ 0,@A;O$X
M7R #)0=A1Q]L=3!'".,A<P#0/UK!#$'@L429J%0NH@&&G9%A6=V !2U @9!B
MV,%1OG &':[W#WSX_^$@X]#%-30QL7]T8D#_: 8I<,$(A,0#G?]@ARR"P0EN
M("01NWC<+H0A"4U.PF&K6 8=^/FT8[0B$*' 4$'_ 8^#@B&7SQB#A\89!XMY
M8EAETD4O,$$W/4!0%\N@1-X8 <1DD,(4G3AF( XBC5Q,PQ,/Z<,J12&,0Y#T
M']DY2#YZ^E.$> ,,A-J%1?WY#S@TXR#!&$4H"+'%Q+)J(SX1!R1PU1-EL (H
MB AI3P112(CD ZL_ 84Q@"*+&/D$'(T@'$],<:+&.L)B/4E$,GZ2C4, )1#7
M^$D[( $4?2PB:3WIQ4!Y$HY%8)0GQZ %4(!1")_,XQ#QHZL/0%8P]ZW2&/\J
MH-ZG$H$K?I#AGK:RA2E(= T04/4@IW"%9KZ!@X&V0Q$H#(<BCN I5_B"D1GU
MPB VHP@+_@,=H%@!;\T!B&+4Y1<@^)(R" %=?[ !#ETQA#!6:0T5%.:ZI>('
M'_+P$&DHPEGF^ 04'D(*76@F&TF YT'@@0CKL@,07H"8.PY1NH/<H@889<8@
MKM<.(J!O1940\$%*H0)S%:,0@'J'&>KP$&(HHC_S>$,5'D(+5#SP&37(Y$'D
M45D(1H()#T*$+,7!BR3D\A>@>%H_H,!9Q2J6OHWE;4]^]9-RO.O-0 D'Q'K"
M9I_DF2?GR"6>@8(.-]/Y,:OT"9Q]8F>@I,-;?_[_R3D$#9$]\^0>UW*.,1'2
MBW>)@QD[0P7!_D&,"?^#.A!AQGY@P=I_((-@S+ L/+YFCC3J%;+>$/4_XD&S
M_?9B9Y4SAJ=F,:A_:"-OW\CU?JN#D%1 ]UN#3=@Q(&*/Q*GC%Q"QQK*-\3UB
MC1<<J+B6/JSQD%ZXV1EM^P<P3%8P7R-D%H#]QS.(O<^'4.-O_Z '+OH$6%R8
MZR7 _(<[J/T0?G@C?;.X<S$2]8]ER%3-#&_'9W_"C%0'_-X_Z4:Y>Q*-9O=$
M'+^XLUN:VQ-Y&)LGN%@V3^#Q<)\8@T(]*<;0$#W7GF!#ECU!QR]XS9-2M!LB
M^(BW3TSAN),_VS_2](G+_X'RC(7[!. ^&0:Z[W-IE0?=+!3W23?VS9-HV!HB
M'!]*C'T"BTI#!!=1Y D];.<39D"V)].PK%]BSA-L:)PG-@]**2"-D)X#Q12F
MY8DP$,X3?12=X6J>!H-_$H:O\>0;> #*&U)!V5K\)!Q/\#-$;+&DGZ""KS_!
M0]YX4@QP_J0,3^=))E3A'PS_9!+/\TDYVL!HGK3A2Z?-JT_FH-^>.$/T/K&'
MZGWR"=3_A!"9]TD;=OZ04&P"*-/(WT_J4/JJ-/XGCX_\Y"O_$\P#10Y]AXCG
M?^(-)/I$#-%_"'=^,H_?]P01]W4][($R^Y^8PO8]P3U0P-"*G_B>\ Q?1S1J
ML?\.L0<,E)(*M$<QZX" Q# (ZV!Y_> =U[ /P@!IZ; .LE *_%!IPC .Y: 4
M$*$."+@.I; KA68K%K0/RT ,%\=1ZS (Q-!WY@!N[0!WX@""ZP *T3!<E1(9
MW$ /WB!I\= /A; .AW80^"!3Q0!RE0."_E (]"!IS< 5QT ./O<@T[ *ZX!S
MSD 5O3!U^@""W& + 9AU!W$,_J!T7;$.H< ,)L<MM>(,BN<R-5@(^1!L+E,8
M[0 ,V@!X".%_L2"&#\$-E/(+!D@.(*B #/@=B &!PF!Y_T"!%A@/&;B!'5@<
M("B"_$""PG80IC .([>"+?B"X%8/D/<0- B"M8"#9A?_&=C0#C[($T HA$0X
M:D?X==&RA$TH:=L0A5/8$^M@A5@($=&PA5.'#C6X"M/P:0<1/V5XAOQ7)^9@
M"7'P"(R@"7!T$+9P">X@#O>09Z-P.8IP"(: "-F&+;!@!7? "KO "VRP9_9
M!IH0"9^P6Q!Q!KA #NA #FZ6")F@"(I0"(4 ",&F#7&  ZP0"[EP!^.UB7^@
M"8N0"0BT&620#?<@#OH ,?L@"9^@"(A@"(>P$P_1"D50! <$"G>0@Y4P!I2P
M")K0(0_1#6  #^G #N3@*<[0D/T8"(HP< AA#K>0!)[ "K[P"1/U)'1@"9\0
M"9I@@)4@"/,@#N9 A*&@"9.@_PB)((X*\Q*%0 *!8 N[8$D0D0U^H F,\ F(
MX''.L 9[,I.>L@V:T @;F9-H]P_1H 9;4!.K\ 3M]!#0*(W4:(W_P O9N(W=
M^(WA.(X(8HYYD([K*(OX\([QZ B65X_W2 Y^MH_]^(^5,"CZX LU\ A!*0D[
M]A"FP) ."9$'H5T369$7F9$;V9$?B2$B29(F"1$HJ9(L"1'" ),R29-*<Y.*
MD),["4&W@ - *91$B1#Z  9'F90&6 B&X)10:1B;H)$<F0BGF0]:R95>>2;.
M>#'RX%0_$0Q[L B8\ F3!1&B< NA0 JJ %GE$ V5, BX@ NB,'5T)5N=)0:8
M  F9H/\B#Q$.MR"@I] +?B8/M] (HE"?KP41E "'#X$.E@ &F+"2;M</ZWD+
MIS!RP" (@D"?HM R"+$'8H<0[; 'CX )D< (@G8-&'H+*%0PW> (MU"?J (1
MR> &0($,9. (F/ (W?D0J;">[0DM_[ .L- )"BH*M041M(">/K$/>T )*?H)
M.X<-&$H*<P<-O@ )"EH*+_<0X D4Q4">YOFD"%$*0^J>"!*?\UF?]ZD+@  4
MH+"?_9E_ "J@&=H+WG(/UM (NE"?QM"(#OH3$3JA%?H=&*JA$,&A'EJ?(7H0
M(QH@)YJB*PH1P>"B,.HRW; (-"H*-IIDR-D3.]JCCV!<$$'_#XJ:<D:*I$K*
MI-YI)^90!7^J"ZIPG_?0"Z[P>0AQ#*,P"J=@!51(,8Q5#;*0B<\ !;Q0JZB
M<_]@#ZXP"LE(,;XZ"HG@!/=Y"\0A#K%0=O\ "E2@"[4JG ^Q#*Y0=0^!#]0:
M!W50:>%04_^ '1X'!VX0KJH IJ.I3KI'K7EP5A!A%0=A#"UI%UPP";6J"M)*
M#K+0+'2'"[Z:"T;0;PB!"_IU"GL8#$(0"[4*"YEX$,S@"@J)$,! K6E0? AQ
M"@ "#K10A[)*J[8Z:;FZJV3HJZ?@!,)*#K_S#]\P"L>J!;:PK,WZK-'*$^1
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ID;VW!E:P@R5L80U[6,0F5K&+96QC'?M8R$96LI.E;&4M>UG,AC(@ #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_008.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M0E[ C:,V0\ H&<? /<6($F$&  4@ 1+P"(G /:90&_UP PF071PP#^!@7P!
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M#(1E 2> #8OQ#^)@K>0PJ86C <"@@V>0#]VJK(6R$<Y0<Z.J><IP"J) >^2
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M.D#%@F!A$_#GM\%>>/# ]'$M<R#Z"W$*-& ")H "*+ #.R#@43+]*:() #$
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MQ&(S*0-":#03&\C#'3:<20.V23'GBB0$97$(:2E U(5 #P#I^<=X#S HD0@
M"A2QWH)US)/9%J01.\C;0>#Q"S1PKQB\N/\'-O;!#E1P Q?+ ,<HEM$+'Q7D
M&J481B'JP0^N$J*2_U#PCAN""CB  1%Z>(8J"""3(40-6!- PAF$B!%W  ..
M*$G#07BA40MXU2,/N$-!:);:0DB2(BFXQ"8)"A'2 N _"N''!0!0 6,6!%$
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MH>A:[4$>]-!'$("EAWE0 ^<KUX<=4<('?3QC*9*F2!EHL6:*_,+HIEAC:T6
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MB-SXAR5 "2/P![&K -%:"':CB *PO"RAB I(A_]G$ D%N A@ @ $T(D:I$.
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MK4OT1 AE  54BX58J,P/M:+_X4H4#4 )&4@&6] WSSJ'/4B !!!4A* # N@
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M><UO8HYX-&[H1'>,X E_DW;$_R/!)1*K.ZSQ^)K4O!_Q4'MD(F,-NM,$\/K
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M[RQ(@QS<(#;D@1J-#B>@'B>D9#.L0BNP^$SXPQQ@A2VD[4Z#0[?_72L0@R/
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MJ^1"H1(401=Z[Q^,@1;_EP4-_@D<!.$0$&&K!J$5_\$?%(%+@743^(1M7 %
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M_,W__-$__=5__=F__=W_A:S!#<Z@"/A@J=5#9M\___5___F___T_10#B&P
M%@9&^O</7#QX_^09X( /(3M_""M:O(@QH\:-'#MZ_ @RI,B1)/]+FCR),J7*
ME2Q;NGP),Z;,E]4 D'EW388"<LAJY+B02!* #2OL79)P0 F_F4R;.GT*-:K4
MJ52K6KV*]5_-,0CQ #C62Q*@"A_Z10#1SQ8 .:< _,D*-Z[<N73KVKV+-VI-
M.0B+ *!6[TR6#!SR%=CQSQ, %2\B0,D+.;+DR90K6[Y\L2855HL H% W!0 R
M%03"&=#QCQ: ,,[HR,(,.[;LV;1KTT8V<* .4?\ ;1"QPX$V(0"\E(OCP@:'
M6K:;.W\./;ITE.F,62?VKJ(T8O* U<L';!I"8K7J33^//KWZ]>S;NW\//[[\
<^?3KV[^//[_^_?S[^_\/8( "#DA@@=("!00 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_009.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_009.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MDD@^'NFCST?=$NSPPQ!'S! (0+#6L,089ZQQN.L($(3%_VXL\L@D=P=- $*
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M@GPG(PH3"#5P&0YT1,8=Z."+0.K1O'_L8S[K* <__H;_#NH![YL #:A(&*$
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M5KOZU;".M:QG3>M:V_K6N,ZUKG?-ZU[[^M? #K:PATWL8AO[V,@F]C*\45E
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M;F,%$W%_4__3 F\P-7! $36X$/Q "HB@"[/P.?X "+E "]P #KY "X3P=;7
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M+B 'B^F(1H,%!%$)4P,E&>&D1O,+8RJD9>I^\D!^1C,%_] *9>,$!(%Z )
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M&& T/; +"\@=$ML0\O] GP_UQX \5/$0NZY7((G<$C'[R*J!P. 2#C1F-'E
MR=GJ$I>,R8?Q#)YP E$ "$!**]T "+#P> "P!: LJJ0\('HP-5ZPR@82#MB0
M>%/C ;Y (012R2PQRK5,&'LP-9?@+<3P7$8C [)"S"MAS,?\$OK0#KD@#>T
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M4X-)6#HUF5 8NT!21% #3$ $)ST0N<@U>U4K-8P15LT,*O@/OU (KR +ZH!
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M0A07%H4?0C#?LM17PA_^#CLRP54 +""A!BCJ=MP1!;90]B#HV%*'/O&/:)C
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M?, ';N &9MA;MNT&8KB%+8B",:@%84 &.& "MG !?&@"+B$!:IA;8I"%)>(
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M\ 5("=>*4(=?2HH(0 $],0ECJ >-+(D<T 91N8(070A[ (;)"8"'PH8[0#8
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MOO$/8)@"+H8U,9*3'"84YP0?^AB$+_]!"D:$ ACN>$4I;]&,6D3$$'13Q/N
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M,AL ^#_H@F'^PR"T@D6  3T8PW_X6+K?QSQX036@@9 A]X<C@AT,@QO$@SL
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M$/!S$;;]!7>A\06!=,MA$ ;R%:;;V<G$'0(!%! !I"O8DD3!A1?"$CZV&N
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3:WO;W.ZVM[\-[G"+>]PM#@@ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_010.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_010.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M/B10%8@]DZ:!&NAMYK<:## "'PAC( !N ;AU$+8.@B<D"H(DR&(/0[07A84
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M "8@$ 90 A*P:7C15LT2*QQF(A^F(&OU@F[EAO#8.(/ ?*[A.@S68 ^ #P"
M>(,&;BX0 L_(&C0G;V%H.0BW$A907P[0<?V0"!8F@9D% #N68P#_\( V]GL5
M.3,>L&M-( :P47 C,(_WX'GI4&4=R6WEIW>KD92])I2W 8@D<4CG)D"/\(!]
M%G0]V3<7B(>NX0*"T(/RUBX   4C, )89W8)P >#L'A15&7XX(>R,88=,2W.
M0PX^QA'WTI6#(X\NQG^L074/<(,)\&QZ4(76HX<'< \C  75J!H@\ ! .)4[
MEQ(4\ C@2%^.YA&H\7E^23=F!V,YJ!HU>'$ ^!JZ97_#IW>C"6XIB7LK*7IC
M$ &-\%LNEQ%]&9I[8X6JUQJ#D'HX"):@AP^5)GTB,&A2>1LV)1/55A)^QIMK
M<PT$@'\8UWKI0&KX$&?,F(]#.0CA)P)S_W4 %E>9MR& *F%NCT "*/ ([Z>;
MH2:=;$-F(7"#($ !P2D"8B (&OA\@4F7JJ&'_0D 8I  ]Q "YFD;3^B<@UB(
M)="9'8%B\KDV#,"?%S<"(O  #S "^#=H8  "?  %H-D:&]F/%P@"RWF>W3@2
M #!(]F /Z6 /[YD183:A;%-D*'< <VA_8("C1R<&8C"BK0%^#48!\ 8":I<;
M5!D2$_ (#> $L:8&O =F7&FC6<.%R@>28)!\QQFDBG=X9R<"# 8"N84<LWD2
MW,$=%;!?>;5N.66E6<, 2?EB]LBE=@@&0JJ:=%6/)X>1(W.9*8&(2[)OV@>G
M9(-X]_F15^ABI?\)IF=6?ZF9&W:I$0@P!@2  NLW '-GJ%DS"/@'!JTG O6)
M=N5G1;<!9U9V#\Z6I[%!?3+Q6Y5* -GGF=7#J5@S5X69=N%6HN'GG;<Q5VE9
M= F0H+>15#!A;FJP96.0F_MAJU$S5QMYGZ4&D@+WF[IA>%5W "*J&\2SHB7A
M8<H"=,CDK$3#F(F'=1FJ?,X8>[M!#_:PD8,6@F9:$\0VH_!)KC-3</I:A2,
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MR[XLR\ <R\)LR[T<S,3\RY.<C998*NFPS,4\S+4<S;ILS-+\S+9<E#W+;!0
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M@UL15'UZ$F"<E8:A&ABD8H /<SB9&[AW[(T> C./((!X)/D 4-!Z9&9QH,H
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MQ'$-_*CO@[2%^ GP77AR*(HK@3X2\# ^ZV "A$K>["N?I!;GR T%8I#^  %
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M ).HB>+_WL('(XYV6S' O/H+<B4][(0J .>F) /*"!F#H,W)4 @ !37',"$
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M!I8[ <!,"% ! M22 OD(42Y#1"9>&J!*P,3J)%4\P]SX)VZ/P@V/1 (8W82
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MB:E" 1/HP<&KE:)3P"$$#T$"F_RP+FK1E8F:MKZ!EOE(.HW3CV$Q"+8  7N
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M$S*//_P.>3!!Z^&9*1.U,Z  CDH(=F@'%I0*#YB]'5"]IG#,QPP1+"(  S"
M_^$#2(,12,LD3N"XNNNK&[(HMJ+DS(%0,N^HRBC1,GG;R)BA'*T4")HXS*8@
M!Y=3JNU\"0*X&=T,@ IP L";C#%P B"$$\HL3IO4 QT) 1%(A] TO(8JD3,X
MNPRP00J0SGK#3L+P  4@L$QDBMQ\3 !0@ Y# #8Q@4\4LU!\3[3\,T/KR5VA
MATU:(Z-1@%"3/^T0".?(  48@*'DE7 848PLQO$DSP @!PN #/:L%?><4,-[
MSHM8BX<(M.FSDW: !WCPRC4Z Q^U(3)8 ?ZLM@%0 'GP /#L#*.!"@0-2P!H
M@#%XA K0( BML*RI42+D+?.(R+CI"*\X&Q7]#J  +O]Y. -&6 !&*# U4CNV
M\T(N4PBB6!ACU$WS])0V48-R^#<:[=+EO ;\.)NTR=%#"E,2*3W5=#)28X0S
M<%&%H  -+9$,;0E*--)1*P=*]32PU$<*0(!^G( S0X#@#$*S#-3#$Q[A>+IQ
M$P/^F!8>#0]+I3\%<+=<)+4%H(-_ "J!2+!QV+DY4=.=TX/=RXCV2RI'5 $G
M91@\;5$=!-145;&QT T^>#SC\95Z,M//H(=U4X$65#<H68"7R\5O,5*9V;V<
M@9GY(Y&@T3<Z8 <%^%:+,(!1.S45. -Y"%"6V<1GY<3AE%:$TQO=N(>Y2!++
M S1950[.* ?OG!(&BS?<(YS_?5. <JV(E/26<%#8,]7/*1FP3%DY.CA) ' .
MF)'$[F%6EG%6?^6[: W8&>**ICLW*'21B  #%S#1SZ" ,Y!81[P>3)D<>K!*
MN6,'H'TU%?!"G@D'3DV.7W7$P7$0*'DU@5 W;XF[=E" E-T:O:0PEB4Z5'U9
M/O,=*3RD!$%8$ @+\#B,=M"WE\NWF$$U]IO!#B$'6U5-Z_G+?6O%WZ '_G+;
ME%3-3'$_P3E9 X4=/3" 0/B'F?3:/P7;L%4Q"HBMDI*1I"R/VSHTOJ4_@>"6
MP7E$I45:J]TWWNN72=$#=NB SZV[(O46>!A$@6A8QWE=J#@,EXLW,BB'M_L9
MFF$[_[:#DMOT#JV-"CT8@$ X@0_0AZYMW!#IAS$1"?\!( OA-0)*!P] (#3)
M,\CM,XKJ/.\;(;<@GD)\"#YXR]&@@'4#TC,H62>[1 (HAU0AV=.3&7;P34IM
M1#KH%L*A@W(H!P7;@0$(D4T*@*/B&53SQ1;4T,,P&C6%F=0]-98*@'^8&7G@
MRB^,NP$P7-$P@#\(! ,0WJ8P@ LX@0(H '!@ <9=WA'+# @P@)EH "[B),D$
M(Q^: "X* #/"JKW57ND)BVO3#WT*"]VQ,=DYR)()C8[E&?\SM5?+@*D-@,-@
MJMAL!SU A \ ASU0".(M!^#BF9W)GL0$P]A4@80@ )J96O^FU= $6P"=FU38
MC<T?C<%6"X=42:, #H!WT#?/M8SDT(,]  <=*.$+( P]((<J+@ =^&-P4-X4
MSHP-\[!;$K&OXJ6Q0C%A0HAT8"E,AI5,YN1-]F1-!N5.#N5/%N52)N53'N54
M-F551N55=N56AF56EN57GN58IN5,1@@YDI'5H "&H@"S(9ZR@8CXF(^RV">6
MXBB#<B=D1BF88F9E]M5T."K4/+L=> <UK3;7)"9$+H /V(/#U(/&?!P"2QZ:
MV3^=:0=?K3L=8DV4XJAN11R$H(>B-=ET'H!N8;N=&3"8B;G#<*J$& #UA0<N
MA!+XG;Y_3J0JJ[($<2F&]M66>FC_3AIA<"CA D $IX*OH.0HM,JICDZ0:]B#
M"Z#H1"Z Y&5DG<@PLNJJ6Y+,K]*J+$(Q7FH F8*LP[+IFL;IS+IIG<[IG?;I
MG@9JGA;JGQ[JH";JHS;JI"[JI38O\G*VDBI;@4BK29O/=,A1$$@F=VHMU<(I
MKJ8IKUX(@;@&1#@!<%"PJ/66#LB&#G!=A)"'M,IB>P!D< "'$XBP08BP<3-!
M8 U*8&1?PEE, "B'7.R9?7OH:W"9TU.!J6YB<X6_*#,U2YS*?G(MMJ(ITWT'
M^>OE:Y@IK1ZN7KYKHA+M['*GM1KIN2X 09:'6<D[CH+K!('MB.Z+"_@ $@:'
MVB;A=4#A_Q1.Z?+T,#+!I<IQLQ([L3/:C!UFF**LTW&CH+EL HP!CD&EFS%]
M"\](!T0X P/0 2M.W7%0ZPY8 14HZS[0@3ZXZ&+5@S] A#T@* ! !+H&9(O.
MR@[)N_I&B)P1M2BA' #PSIG)10*8E!&43F%45TM"0?9UQ S(5QU."*8Z@W#0
MUZH@Y'#.B#\881U 9$#6 2H&APM !$28W8N@< #PXXH^@0\_@0MPL)/&"1.P
M@'6HB'7PGS?[GZ"A<0( (SO#7CU#[CK9BB 9BY,YCX$0"#T@"O=XC2E,E(M@
MI+4I#*8: -K^  SO@S]6:T*8<G@X@0Q'Y ] !(2@[=1.<=H&Y/^R_H +Z(</
M1X19R8C#B&-,$5D:_ ?_O!X#WDM<!4P<PKG\WB'F.(-K^. &9_"F"(0/#X0O
MT^X3*.O;?H)%OP! _@#DO>(/-@"R5O021F1$<!6!:&$6MXD],Y=7*9A@TQYZ
M1!-.@E#-8-H>5Y"''($_E("[\8@$B(V"R*V"Z$-!H(!KN(8,%H@!$!:(,&*J
M<!DR*&&Z_F-$INA#!@="8/8,I^LM5_:*KNBZ;G2Z+N$/.(<+V%>JI<%X0[UP
M8 #>K3T8O,4#_^\:NL0I"0<7S4H2.5[D_6:!0 0=N( P/^0M[X<+8'9D!X<^
M*( 38 D.QVUNMNN\(P?Q]'0[;("<9?7_-HH*&L.@0 $ ?&"6_. 1X3@ :9$6
M85^=K<B(V](+EY**[@$ %6"$*<EP\@[X9Z=H*A_I0[;MET]DU-8![49M<- '
M05Z) 1!1KLQ4F9$'<4Y#%%0 _5SW!0-1JQP'?BL1XCT!?:#H%-_RF"=IGB_K
MBH[O,I<4<J#MFL]W*UODA6>=!@CTA[^('X<"BS*/_6C(NWBC84E"%W"'A_ 5
M#40)N6@"1%L)$>CX#MK6C% W]8WC#M#P1#[M B!O;K9W':CZ#&]Y:O_C)]@#
M>Q#IFK]M1 #G,A0N/<!O^1T'/V6BDR\UU+/!H](W>60B;L':01^-$2=# #A\
M;HYY;B;A"PB1_XF>ZR=X@0S? ^PD9'D(A$>O_3._"(4G^ZB24+0G#JTCH4--
M%H='"+UQBQ>9BZW;C;R1D>>!(?,CCG+$C6W%SECOV"A9@/+^XY8O\_+&<)$N
MX2_GJ"J^\*FO]PZ_  / 2O<^9);'="8*9ST B'2(3ACP  " 'CWDSNS8D0%>
M.Q4'#Y)CMV/<N(L9=Y0+ (""B@P2)Q[4XY$DRI0J5T[4HS(A@ L7#+@$\,<
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MJ5C+*$5!1-4FHLY^WK%]S(2?]&QV/GGPIR0*V5&G$.&;K0!4FV(A2R8SRD#
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M!_A) BJ1&0X>1NQ&R*&8"D!31IR!I)T!H@A(/15?4!C% GS:Q97,19A/ #
MMQB*H50' ! 'VH#(%*K$?01+.#%/LS0%'U$(&^F!MI0+3,2?0IQ/1[F$(WU
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M),U)8J>)&F,P5B=C 0ZCN20RMDY+80X 0($5PM)BN ,?+,*[1*8@3-L?O,-
M%,6Q?, Y?/\ "Z@AB?S1V<C$(H%1 """=N#5&8#-"=28(^QF7I##"V@%@WI'
M@,K-$UP# R@2>UV#X$B4<B#""RB4.A&%4P3;5"""MLQ1M>A?J>&)K U(%M5/
MS9!#/T3+]?S;B0XJH6[=WJBH=<Y%CFB,3F(.,C[<H@( V;F;%::)VND+%"@.
M+(U)89#4(O3!S)Q ,JQ/'_!1!Y (\AW-'$I+ 9S!\C I,T7D1FX*<T2<!"@7
M.4#&M^6*3/0#>QG%LAV/7YG@K) #HR!".N0@0OQ!KYW 3:"@<](%(OB*\&1
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M7(<#> 0"E -93/_ H1+ )31< ;?&P6!N"-Q#8;@#"+0N$X< ^7E?ZRY"!Y@
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M# 6'#H1RA.G+%;?0QC?RUJ"QG!&)I_@4&D":U7<#V4CG,2I>2( *]$8Y#,"
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MYKMN00="6\_ H0H\\+NCTID0HZ1H>PZZU4!TRC_A"$@KN:*:.^K$X1;S2KP
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M,2M:P(VRQ0 KK6/R)EH4<K#%HQDE#U9LBA[V%*53 2 '!*PT_YVTT .H%#
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M,2'@'Q[S<"(S\:RD*FY-5*A-6_X! GJ*,PTR*0B >-3R.L '+12 %VDJ+DD
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M*;[B>3W89WT,+H/@DUT-!H#;&\ >QD -OF$,,-OB43[E5=[3!V!?#("7;&,
M%, #. LY)'[E<3[G=7[G>;[G??[G@3[HA7[HB;[HC?[HD3[IE7[IF;[IF3X@
#   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000831001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Citigroup Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-270327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Oct. 30, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">470,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 4,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 649.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 4,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">649.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">649.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 4,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp236486_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp236486_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp236486_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp236486_exfilingfees.htm">dp236486_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp236486_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp236486_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2024": 3,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236486_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236486_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236486_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236486_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236486_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236486_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000950103-25-013806-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-013806-xbrl.zip
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MTIP8<XC@.M-SAQOQG*1S6HCGA<;G)97+'<PC-9ID08<A35C(R@@0 G:[YG)
M6 @ I7\0;%:/$#H35%BD"M$ @HS<F/PL&]R2BS81&$E4:?+? 1V>*W+S$4>D
M9>10D!%<G2N"C$76=Z>L_UPV0'_6<<T)XF)BD7.E"\"PNU5/H#:U"4<M,D*W
MKHV=5' C!1[/:!>X.SHSZ3!\SJ0<8M&D@AS7(8J/GHXKD@!A\FIZ34V3.,%U
M< ? 6P,;,!K(@4T$#'3-RMV@8U/.G;8WY7XL;DGW7#&^,N*Y3"B(@O+H>)C6
M-4VIYO7\A7Z6G<.VD08H<1K<DE#1E>J[QW2C>=UL7:'&NW=WVY #TU?>.6"O
M21WLP+#5=$PR_D FF^GFE*H*?TYRFJIJVXIX2WJ.3""MSF9"X&ZY7"ZME]2<
M7EI%*+M@0DF9D2YAD/\(C\#DGJAPHT]L#/20'Y8J?29)2R_EJSQ>_DC+'YDQ
M-Y7I<P)\^%SA%%(="?PV8F61=, .=P<LSHT?""M3^7V)C:]N%YZ$K?154T*X
M")+XEIK=CA:H*9>ZE##D"T>6QI9Z\\.\S18?7H*9DYX-R_&5Z9I)?068'XG=
M ;HF[$#'KSM\ ]],Q:B-*5>J9]+/9&!KN56@&[LZR[[$M4 LNY*3<&E1+U/>
M/># -9<))3 3EU">5,&DA;2FIG-J1"9:>_D<<<P53X4K2YA;Y"*\/S5[,F?0
M?U%GT/]VAL3.,(V,/]81?CTE#QP::/C^[O*E<FV"^8"1ZK1LK !0B"Y<>D%'
M8EQ%Q(,G5E.9\@\_OXL([V-(-IO(!%#;$<J^S&-!ZHVJ*=C0="@K,"^LOVS,
M>M1)"]>K("C>3M'T1L<5PK6AHM/E35G=I3G]1L(;TE1I;-$>M'2,]OHAS(C(
MBPKJN)8)I<\X/5=Z>EN1+FZD;("G$[:4=+UV7;^_KK6;-RUTTT"S"@RU:Q?7
ML@X[(#.KBTEH(!*4D?D3I7J7SBV65]O*H'Z70JF@/>8./'1EN1ULH8^8/1/!
MT7M8!A-SU'2,S+8L)7"O;?4ZJYJACJ5<-FI"]MF;M5R.2PG2+.H[DT*8HZL!
MEBA=MBAKQV6PS0)9KQB>H!PT0Z8[Z%AD7D1-BNAA4ZHM "\F%CK2X$J5YCU(
M0VT,5)%6D6V8-4&!)J#H-1%V3%3'C$WD2&B$F0E]F3%@('>T0X7_L$$L:\KD
MN:(J_C7WL!%>QQJ_4#"?G:D:#->RL,?A=OCK%(VH*?H23OV7[%(%6X+$M_^0
M,$$-;(7J"&1+[!=^YVN&R$.J.A#]]S^UHGH*3;"Y'$C-%!) :4F #HZJF @J
M&:Z3G6$J[TY5"6!V:)B#RG98OA>L"_^P5=OQ9.?;<1H?PG!U86'C&4%(1-RU
M*$!?0[N!FH+82(ZAE@@11LXHA\B MU+D3>2FT6]R8&IU"W..VG(6MW>B+5?X
M@[_]4I%C_SJVC('ECT3/.BQ;1;># \A7L]V!(V))+H9C"5;(1Y#'H/O5E:04
M/C'7<SEDSX]X3.V!C<*F.9#R$U0'!'V"5NX>ZO&=4P^)UGH]1GKRM5!(/J!\
M$-/> MV=2S:UG-M%8:TF74=V"QL#T](Z 8JB^:ADD:Y05K+\]YW#WWEATZUL
M&'.RF9?-E=*QAD*N5A 5@,=8GJP6MXDNM\F+DCE>('^_!&$J[E-!TK*@)O+E
MQXAA;TVC^(F1(;<FG\R&U5ML9&)#:12\D9(-C:AT7-<BV.EB2[YFBMJ<@NIO
M: YLH@Y$+4S-EXWENGW^*@'"B'5GB,G+CC<NPHQ13:E>DH[8BKN$'$#>3<:#
MGK3S11^)20=VNDV8#1[C4)<A/_$&+[[D&[%7J?FEVRK58^WMJY]=_=8'4G6^
M4&+;>YA@@SD'RRE50'3,WGZWP/YH*>*YP;#AYX<9TS5;@#U!N[!=307)<9C/
M\W3(ADQB4!LV@-^QQEEW!K;IBNER,E?(@U@E-:6J:BA7R- &E_SM>Z6$ B#T
M7IGPH="03AP35TY'8[(V6XWOEK:@5+4?(2@4.2(N['ZE+()-4R7U%59-L,>6
M" B!5Q92,:'\F?..I2HI534#$FFY$^W0)@0)85/NUVHG2K68+V?4TG+A?MH$
MK2=+T.6?.$'K,4:+4$G<B#YAA\[0<TQH"U/;3#BAA:8%&HM#IF5]#VE9>@(H
MF<GTO+UO+:3FHOX:B_V,F7G.!>1IEU\T)\_)F0_B^J^8E>?D++Q&SI\L(<\)
M5/SU$O*<?*5U!ELWQ<EO/<59''<GF7<G@MG5<'UGB/8T[?_A> XB^_K)X^Q5
MY YP[$HO_\<R[VJHI^65-3&N[0ILS6;?P?"85_8</]O"BH[(R3BZ_!1!\G@Z
M'X=G,?3DU:WHICN[4D.82?:E@?)>V[JMG,SOOV1/1]T!M'5^$[;!T0YXY[4&
MC)K4?9JQI&Y5#.S7B#):<+(Q2.S=4IM>A+TZ'K\BE($^]FI_[<?;OT6$;_W+
M ?DI+3\[&:8LC<P;'MK2[*"-/8?NDIXH=&?]DV5SA^:"[X;D.1%YU 35&,56
M"KTGUI!(MTBA.^SPM/_IT*FTOLM X%[GN*"F-%5+Z87"V\U'XM3XVV_O!?TU
M!^R*RX^"*M6OB?_X1P2.HJI%#I^.^=N='+5+=&AUY:&[C3OOKP$7M#M9U7D5
MEAX$GKV=6E+A@N:R:W)81'#CB%!J44&$&UA^Y:,E&AN7<I 8^@1U@R/)78@/
M'J1U4)#H(]&G/%SQ!HP/L"/D %:.W5#P-@N<'S8E0)+8&V%4,_SS"UHYE_./
MAP*K &:B8PFGS ,J;U-H!# N:(HZV(+"PI3?(LF7S-1!V#!@W\N/*P.>IK2+
MQYT8[:-YE)FED[Q@OX&>9SONE_0T_>?QM/@\I)27AZX0)QYF\K@./,(IV"\X
MW3*BEB4'^XP8A [!]!!O?:_JA7/KE']*=ZD;.JO=,(6<&$T6/U C?1W\V\,3
MZ06)?2;9T>;]GF1N82:%&$(RI]RP7.Y_?['ZE/G*B'TD][X]/4J%HZ-4H0&1
MYQ_B@JTL-<MGF@7MC_K4Z/OW/>9RCQABP$'!\AMZ+O7ZVYK<RY@8+AV@OC;I
M;CC%7BJLZR,S:SYL=: _X)XA^)+7#"&9S:\82D4_RA[%- 4:PA!;(>#%]1=Z
M?:!',S+$$N]\A;7CV1X*#_FILBQ Y%?,U?\!4$L! A0#%     @ #'A=6\FS
M&V-1"P  BD$  !D              ( !     &1P,C,V-#@V7V5X9FEL:6YG
>9F5E<RYH=&U02P4&      $  0!'    B L

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>dp236486_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-30</startDate>
            <endDate>2025-10-30</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-30</startDate>
            <endDate>2025-10-30</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
        </entity>
        <period>
            <startDate>2025-10-30</startDate>
            <endDate>2025-10-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="ixv-211">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="ixv-212">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="ixv-213">0000831001</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="ixv-214">333-270327</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="ixv-248">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="ixv-249">Citigroup Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="ixv-250">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-251">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="ixv-253">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="ixv-254"
      unitRef="shares">470000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-255"
      unitRef="USD">10</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-256"
      unitRef="USD">4700000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-257"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">649.07</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="ixv-259">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-260">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="ixv-262">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="ixv-263"
      unitRef="shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-264"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-265"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-266"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-267"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-268"
      unitRef="USD">4700000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-269"
      unitRef="USD">649.07</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-270"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-271"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-272"
      unitRef="USD">649.07</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-275"
      unitRef="USD">4700000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-276">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
